Sin-Ho Jung
Professor of Biostatistics & Bioinformatics
Design of Clinical Trials
Survival Analysis
Longitudinal Data Analysis
Clustered Data Analysis
ROC Curve Analysis
Design and Analysis of Microarray Studies
Big Data Analysis
Survival Analysis
Longitudinal Data Analysis
Clustered Data Analysis
ROC Curve Analysis
Design and Analysis of Microarray Studies
Big Data Analysis
Current Appointments & Affiliations
- Professor of Biostatistics & Bioinformatics, Biostatistics & Bioinformatics, Basic Science Departments 2006
- Member of the Duke Cancer Institute, Duke Cancer Institute, Institutes and Centers 2021
Contact Information
- 2424 Erwin Road Ste 1102, 11076 Hock Plaza, Durham, NC 27705-3858
- Duke Box 2721, Durham, NC 27710
-
sinho.jung@duke.edu
(919) 668-8658
- Background
-
Education, Training, & Certifications
- Ph.D., University of Wisconsin - Madison 1992
-
Previous Appointments & Affiliations
- Associate Professor of Biostatistics & Bioinformatics, Biostatistics & Bioinformatics, Basic Science Departments 2003 - 2006
- Associate Professor of Biostatistics & Bioinformatics, Biostatistics & Bioinformatics, Basic Science Departments 2002 - 2003
- Instructor, Temporary of Biostatistics and Bioinformatics, Biostatistics & Bioinformatics, Basic Science Departments 2001 - 2002
- Recognition
-
Awards & Honors
- Research
-
Selected Grants
- Harnessing treatment-induced tumor evolution and collateral sensitivities using a human rectal cancer co-clinical platform awarded by National Institutes of Health 2022 - 2027
- Integrated Biostatistical Training for CVD Research awarded by North Carolina State University 2022 - 2027
- An Integrated Biomarker Approach to Personalized, Adaptive Deep Brain Stimulation in Parkinson Disease awarded by National Institutes of Health 2023 - 2027
- RAPID System for Early Detection of Head and Neck Cancer in Low-Resource Settings awarded by National Institutes of Health 2022 - 2027
- Role of the tumor NLRP3 inflammasome in the generation of anti-PD-1 antibody immunotherapy-associated toxicities awarded by National Institutes of Health 2021 - 2026
- Integrated analysis of a NLRP3-dependent adaptive resistance mechanism to pembrolizumab immunotherapy in advanced gastroesophageal cancer awarded by Merck Sharp & Dohme 2022 - 2026
- Adapting K-MDS to detect KRAS-mutant ctDNA awarded by National Institutes of Health 2022 - 2025
- Ewing-like sarcoma: Targeting the CIC-DUX4 oncogene through epigenetic regulators awarded by Department of Defense 2022 - 2025
- A Randomized Phase 2 Trial to Evaluate Prebiotic Intervention in Allogeneic Hematopoietic Stem Cell Transplantation awarded by National Institutes of Health 2020 - 2025
- Home-based Autologous Hematopoietic Stem Cell Transplantation to Improve Outcomes and Decrease Costs awarded by National Institutes of Health 2020 - 2025
- PVSRIPO in melanoma awarded by National Institutes of Health 2020 - 2025
- Investigating the Role of a Novel Dendritic Cell Subset within Sentinel Lymph Node Tissues in Immune Evasion and Melanomagenesis awarded by Department of Defense 2021 - 2024
- Clinical Biomarker Study of the Tumor NLRP3 Inflammasome and its Role in Anti-PD-1 Immunotherapy Resistance awarded by Conquer Cancer Foundation 2021 - 2024
- Dissecting Mechanisms by which p53 Suppresses Transformation and Radiation Carcinogenesis awarded by National Institutes of Health 2020 - 2022
- Evaluating Effects of Age-related Microbiota Modulations in Hematopoietic Stem Cell Transplant Patients awarded by National Institutes of Health 2019 - 2022
- Patient-centered home-based hematopoietic stem cell transplantation awarded by National Institutes of Health 2016 - 2022
- Innovative Biomarker-Integrated Clinical Trial Design and Analysis awarded by University of North Carolina - Chapel Hill 2015 - 2020
- Statistical/Computational Methods for Pharmacogenomics and Individualized Therapy awarded by University of North Carolina - Chapel Hill 2015 - 2020
- National Clinical Trials Network - Network Group Statistics and DMCs awarded by Mayo Clinic 2014 - 2017
- Alliance NCORP Research Base - Clinical Trials - CALGB 70807 awarded by Mayo Clinic 2016 - 2017
- ETIOLOGY OF COPD AMONG CONSTRUCTION WORKERS awarded by National Institute for Occupational Safety and Health 2011 - 2015
- CTSA UL awarded by National Institutes of Health 2006 - 2012
- Cancer and Leukemia Group B Statistical Center awarded by National Institutes of Health 1982 - 2010
- Dendritic Cell Based Immunotherapy awarded by National Institutes of Health 2002 - 2007
- Publications & Artistic Works
-
Selected Publications
-
Books
-
Jung, S. H. Design and analysis of phase II cancer clinical trials, 2016. https://doi.org/10.1201/9781315371566.Full Text
-
Jung, S. H. Randomized phase II cancer clinical trials, 2013. https://doi.org/10.1201/b14751.Full Text
-
-
Academic Articles
-
Yerokun, Babatunde A., Prashanth Vallabhajosyula, Andrew M. Vekstein, Maria V. Grau-Sepulveda, Ehsan Benrashid, Ying Xian, David N. Ranney, et al. “Long-term outcomes of aortic root operations in the United States among Medicare beneficiaries.” J Thorac Cardiovasc Surg 165, no. 2 (February 2023): 554-565.e6. https://doi.org/10.1016/j.jtcvs.2021.02.068.Full Text Link to Item
-
Rutherford, Sarah C., Jun Yin, Levi Pederson, Gabriela Perez Burbano, Betsy LaPlant, Mazyar Shadman, Hongli Li, et al. “Relevance of Bone Marrow Biopsies for Response Assessment in US National Cancer Institute National Clinical Trials Network Follicular Lymphoma Clinical Trials.” J Clin Oncol 41, no. 2 (January 10, 2023): 336–42. https://doi.org/10.1200/JCO.21.02301.Full Text Link to Item
-
Patel, Rutulkumar, Yvonne M. Mowery, Yi Qi, Alex M. Bassil, Matt Holbrook, Eric S. Xu, Cierra S. Hong, et al. “Neoadjuvant Radiation Therapy and Surgery Improves Metastasis-Free Survival over Surgery Alone in a Primary Mouse Model of Soft Tissue Sarcoma.” Mol Cancer Ther 22, no. 1 (January 3, 2023): 112–22. https://doi.org/10.1158/1535-7163.MCT-21-0991.Full Text Open Access Copy Link to Item
-
Liu, Lu, Shiwei Cao, and Sin-Ho Jung. “Optimal designs for phase II clinical trials with heterogeneous patient populations.” J Biopharm Stat 33, no. 1 (January 2, 2023): 1–14. https://doi.org/10.1080/10543406.2022.2065499.Full Text Link to Item
-
Issa, Khalil, Jordan Teitelbaum, Blaine D. Smith, Frances Wang, Feras Ackall, Zoukaa Sargi, Sanjeet V. Rangarajan, Sin-Ho Jung, David W. Jang, and Ralph Abi Hachem. “Nasal Cavity Squamous Cell Carcinoma: Factors Associated With Treatment Outcomes and Potential Organ Preservation.” Am J Rhinol Allergy 37, no. 1 (January 2023): 35–42. https://doi.org/10.1177/19458924221130133.Full Text Link to Item
-
Li, Jianghao, and Sin-Ho Jung. “Group sequential testing for cluster randomized trials with time-to-event endpoint.” Biometrics 78, no. 4 (December 2022): 1353–64. https://doi.org/10.1111/biom.13498.Full Text Link to Item
-
Venkatraman, Vishal, Elayna P. Kirsch, Emily Luo, Sameer Kunte, Madison Ponder, Ziad F. Gellad, Beiyu Liu, et al. “Outcomes With a Mobile Digital Health Platform for Patients Undergoing Spine Surgery: Retrospective Analysis.” Jmir Perioper Med 5, no. 1 (October 26, 2022): e38690. https://doi.org/10.2196/38690.Full Text Link to Item
-
Byers, Isabelle S., Nicholas A. Turner, Nicole L. Levine, Alexander L. Lazarides, Daniel R. Evans, Ivan Spasojevic, Ping Fan, et al. “Antibiotic Prophylaxis for Megaprosthetic Reconstructions: Drug and Dosing May Matter More than Duration.” Antimicrob Agents Chemother 66, no. 10 (October 18, 2022): e0014022. https://doi.org/10.1128/aac.00140-22.Full Text Link to Item
-
Beasley, Georgia M., Michael C. Brown, Norma E. Farrow, Karenia Landa, Rami N. Al-Rohil, Maria Angelica Selim, Aaron D. Therien, et al. “Multimodality analysis confers a prognostic benefit of a T-cell infiltrated tumor microenvironment and peripheral immune status in patients with melanoma.” J Immunother Cancer 10, no. 9 (September 2022). https://doi.org/10.1136/jitc-2022-005052.Full Text Link to Item
-
Jacobs, Corbin D., Ian Barak, Sin-Ho Jung, Daniel J. Rocke, Russel R. Kahmke, Gita Suneja, and Yvonne M. Mowery. “Prediction model to estimate overall survival benefit of postoperative radiotherapy for resected major salivary gland cancers.” Oral Oncol 132 (September 2022): 105955. https://doi.org/10.1016/j.oraloncology.2022.105955.Full Text Link to Item
-
Lazarides, Alexander L., Etienne M. Flamant, Mark M. Cullen, Harrison R. Ferlauto, Niall Cochrane, Junheng Gao, Sin-Ho Jung, Julia D. Visgauss, Brian E. Brigman, and William C. Eward. “Investigating readmission rates for patients undergoing oncologic resection and endoprosthetic reconstruction for primary sarcomas and tumors involving bone.” J Surg Oncol 126, no. 2 (August 2022): 356–64. https://doi.org/10.1002/jso.26864.Full Text Link to Item
-
Mitchell, Kyle T., Stephen L. Schmidt, Jeffrey W. Cooney, Warren M. Grill, Jennifer Peters, Shervin Rahimpour, Hui-Jie Lee, et al. “Initial Clinical Outcome With Bilateral, Dual-Target Deep Brain Stimulation Trial in Parkinson Disease Using Summit RC + S.” Neurosurgery 91, no. 1 (July 1, 2022): 132–38. https://doi.org/10.1227/neu.0000000000001957.Full Text Open Access Copy Link to Item
-
Sung, Anthony D., Vinay K. Giri, Helen Tang, Krista Rowe Nichols, Meagan V. Lew, Lauren Bohannon, Yi Ren, et al. “Home-Based Hematopoietic Cell Transplantation in the United States.” Transplant Cell Ther 28, no. 4 (April 2022): 207.e1-207.e8. https://doi.org/10.1016/j.jtct.2022.01.015.Full Text Link to Item
-
Park, S., J. -. M. Sun, Y. -. L. Choi, D. Oh, H. K. Kim, T. Lee, S. A. Chi, et al. “Adjuvant durvalumab for esophageal squamous cell carcinoma after neoadjuvant chemoradiotherapy: a placebo-controlled, randomized, double-blind, phase II study.” Esmo Open 7, no. 1 (February 2022): 100385. https://doi.org/10.1016/j.esmoop.2022.100385.Full Text Link to Item
-
Li, Jianghao, and Sin-Ho Jung. “Sample size calculation for clustered survival data under subunit randomization.” Lifetime Data Anal 28, no. 1 (January 2022): 40–67. https://doi.org/10.1007/s10985-021-09538-0.Full Text Link to Item
-
O’Connell, Avice M., Tommaso V. Bartolotta, Alessia Orlando, Sin-Ho Jung, Jihye Baek, and Kevin J. Parker. “Diagnostic Performance of an Artificial Intelligence System in Breast Ultrasound.” J Ultrasound Med 41, no. 1 (January 2022): 97–105. https://doi.org/10.1002/jum.15684.Full Text Link to Item
-
Thompson, Jillian C., Yi Ren, Kristi Romero, Meagan Lew, Amy T. Bush, Julia A. Messina, Sin-Ho Jung, et al. “Financial incentives to increase stool collection rates for microbiome studies in adult bone marrow transplant patients.” Plos One 17, no. 5 (2022): e0267974. https://doi.org/10.1371/journal.pone.0267974.Full Text Link to Item
-
Liu, Lu, Kevin J. Parker, and Sin-Ho Jung. “Design and Analysis Methods for Trials with AI-Based Diagnostic Devices for Breast Cancer.” J Pers Med 11, no. 11 (November 4, 2021). https://doi.org/10.3390/jpm11111150.Full Text Link to Item
-
Patel, Arsh, Jane S. Kim, Jason Liss, Lauren Howard, Sin-Ho Jung, and Meenal Kheterpal. “Outcomes of adjunctive therapies post hedgehog inhibitors in the management of locally advanced basal cell carcinoma: A systematic review and pooled analysis.” Dermatologic Therapy 34, no. 6 (November 2021): e15172. https://doi.org/10.1111/dth.15172.Full Text
-
Bohannon, Lauren, Helen Tang, Kristin Page, Yi Ren, Sin-Ho Jung, Alexandra Artica, Anne Britt, et al. “Decreased Mortality in 1-Year Survivors of Umbilical Cord Blood Transplant vs. Matched Related or Matched Unrelated Donor Transplant in Patients with Hematologic Malignancies.” Transplantation and Cellular Therapy 27, no. 8 (August 2021): 669.e1-669.e8. https://doi.org/10.1016/j.jtct.2021.05.002.Full Text Open Access Copy
-
Zheng, Yi, Clarissa A. Cassol, Saemi Jung, Divya Veerapaneni, Vipul C. Chitalia, Kevin Y. M. Ren, Shubha S. Bellur, et al. “Deep-Learning-Driven Quantification of Interstitial Fibrosis in Digitized Kidney Biopsies.” Am J Pathol 191, no. 8 (August 2021): 1442–53. https://doi.org/10.1016/j.ajpath.2021.05.005.Full Text Link to Item
-
Farrow, Norma E., Eda K. Holl, Jeanne Jung, Junheng Gao, Sin-Ho Jung, Rami N. Al-Rohil, Maria A. Selim, et al. “Characterization of Sentinel Lymph Node Immune Signatures and Implications for Risk Stratification for Adjuvant Therapy in Melanoma.” Ann Surg Oncol 28, no. 7 (July 2021): 3501–10. https://doi.org/10.1245/s10434-020-09277-w.Full Text Link to Item
-
Lee, Chiyoung, Qing Yang, Eun-Ok Im, Eleanor Schildwachter McConnell, Sin-Ho Jung, and Hyeoneui Kim. “The Contribution of Material, Behavioral, Psychological, and Social-Relational Factors to Income-Related Disparities in Cardiovascular Risk Among Older Adults.” J Cardiovasc Nurs 36, no. 4 (July 2021): E38–50. https://doi.org/10.1097/JCN.0000000000000808.Full Text Link to Item
-
Wood, Marie E., Heshan Liu, Elizabeth Storrick, David Zahrieh, H Carisa Le-Petross, Sin-Ho Jung, Patricia Zekan, et al. “The Influence of Vitamin D on Mammographic Density: Results from CALGB 70806 (Alliance) a Randomized Clinical Trial.” Cancer Prevention Research (Philadelphia, Pa.) 14, no. 7 (July 2021): 753–62. https://doi.org/10.1158/1940-6207.capr-20-0581.Full Text
-
Eichenberger, Emily M., Felicia Ruffin, Michael Dagher, Reginald Lerebours, Sin-Ho Jung, Batu Sharma-Kuinkel, Andrew N. Macintyre, et al. “Bacteremia in solid organ transplant recipients as compared to immunocompetent patients: Acute phase cytokines and outcomes in a prospective, matched cohort study.” Am J Transplant 21, no. 6 (June 2021): 2113–22. https://doi.org/10.1111/ajt.16388.Full Text Open Access Copy Link to Item
-
Tang, Helen, Lauren Bohannon, Meagan Lew, David Jensen, Sin-Ho Jung, Aaron Zhao, Anthony D. Sung, and Paul E. Wischmeyer. “Randomised, double-blind, placebo-controlled trial of Probiotics To Eliminate COVID-19 Transmission in Exposed Household Contacts (PROTECT-EHC): a clinical trial protocol.” Bmj Open 11, no. 5 (May 5, 2021): e047069. https://doi.org/10.1136/bmjopen-2020-047069.Full Text Open Access Copy Link to Item
-
Jung, S. H. “Design and analysis of cancer clinical trials for personalized medicine.” Journal of Personalized Medicine 11, no. 5 (May 4, 2021). https://doi.org/10.3390/jpm11050376.Full Text
-
Ackall, Feras Y., Khalil Issa, Ian Barak, Jordan Teitelbaum, David W. Jang, Sin-H Jung, Bradley Goldstein, Ricardo Carrau, and Ralph Abi Hachem. “Survival Outcomes in Sinonasal Poorly Differentiated Squamous Cell Carcinoma.” Laryngoscope 131, no. 4 (April 2021): E1040–48. https://doi.org/10.1002/lary.29090.Full Text Link to Item
-
Beasley, Georgia M., Smita K. Nair, Norma E. Farrow, Karenia Landa, Maria Angelica Selim, Carol Ann Wiggs, Sin-Ho Jung, et al. “Phase I trial of intratumoral PVSRIPO in patients with unresectable, treatment-refractory melanoma.” J Immunother Cancer 9, no. 4 (April 2021). https://doi.org/10.1136/jitc-2020-002203.Full Text Link to Item
-
Sohani, Aliyah R., Matthew J. Maurer, Sharmila Giri, Brandelyn Pitcher, Amy Chadburn, Jonathan W. Said, Nancy L. Bartlett, et al. “Biomarkers for Risk Stratification in Patients With Previously Untreated Follicular Lymphoma Receiving Anti-CD20-based Biological Therapy.” Am J Surg Pathol 45, no. 3 (March 1, 2021): 384–93. https://doi.org/10.1097/PAS.0000000000001609.Full Text Link to Item
-
Giri, Vinay K., Kristin G. Kegerreis, Yi Ren, Lauren M. Bohannon, Erica Lobaugh-Jin, Julia A. Messina, Anita Matthews, et al. “Chlorhexidine Gluconate Bathing Reduces the Incidence of Bloodstream Infections in Adults Undergoing Inpatient Hematopoietic Cell Transplantation.” Transplant Cell Ther 27, no. 3 (March 2021): 262.e1-262.e11. https://doi.org/10.1016/j.jtct.2021.01.004.Full Text Link to Item
-
Issa, Khalil, Feras Ackall, Sin-Ho Jung, Jianghao Li, David W. Jang, Sanjeet V. Rangarajan, and Ralph Abi Hachem. “Survival outcomes in sinonasal carcinoma with neuroendocrine differentiation: A NCDB analysis.” Am J Otolaryngol 42, no. 2 (2021): 102851. https://doi.org/10.1016/j.amjoto.2020.102851.Full Text Link to Item
-
Lee, Chiyoung, Qing Yang, Eun-Ok Im, Eleanor Schildwachter McConnell, Sin-Ho Jung, and Hyeoneui Kim. “A 10-year trend in income disparity of cardiovascular health among older adults in South Korea.” Ssm Popul Health 12 (December 2020): 100682. https://doi.org/10.1016/j.ssmph.2020.100682.Full Text Link to Item
-
Li, Jianghao, and Sin-Ho Jung. “Sample size calculation for cluster randomization trials with a time-to-event endpoint.” Stat Med 39, no. 25 (November 10, 2020): 3608–23. https://doi.org/10.1002/sim.8683.Full Text Link to Item
-
Teitelbaum, Jordan I., Khalil Issa, Ian R. Barak, Feras Y. Ackall, Sin-Ho Jung, David W. Jang, and Ralph Abi Hachem. “Sinonasal Squamous Cell Carcinoma Outcomes: Does Treatment at a High-Volume Center Confer Survival Benefit?” Otolaryngol Head Neck Surg 163, no. 5 (November 2020): 986–91. https://doi.org/10.1177/0194599820935395.Full Text Link to Item
-
Hu, Janice B., Surya Ravichandran, Christel Rushing, Georgia M. Beasley, Brent A. Hanks, Sin-Ho Jung, April K. S. Salama, Lisa Ho, and Paul J. Mosca. “Higher BMI, But Not Sarcopenia, Is Associated With Pembrolizumab-related Toxicity in Patients With Advanced Melanoma.” Anticancer Res 40, no. 9 (September 2020): 5245–54. https://doi.org/10.21873/anticanres.14528.Full Text Link to Item
-
Thanarajasingam, Gita, John P. Leonard, Thomas E. Witzig, Thomas M. Habermann, Kristie A. Blum, Nancy L. Bartlett, Christopher R. Flowers, et al. “Longitudinal Toxicity over Time (ToxT) analysis to evaluate tolerability: a case study of lenalidomide in the CALGB 50401 (Alliance) trial.” Lancet Haematol 7, no. 6 (June 2020): e490–97. https://doi.org/10.1016/S2352-3026(20)30067-3.Full Text Link to Item
-
Kim, Su Mi, Byung-Hoon Min, Joong Hyun Ahn, Sin-Ho Jung, Ji Yeong An, Min Gew Choi, Tae Sung Sohn, et al. “Nomogram to predict lymph node metastasis in patients with early gastric cancer: a useful clinical tool to reduce gastrectomy after endoscopic resection.” Endoscopy 52, no. 6 (June 2020): 435–43. https://doi.org/10.1055/a-1117-3059.Full Text Link to Item
-
Maung, Ko, Sendhilnathan Ramalingam, Mohammad Chaudhry, Yi Ren, Sin-Ho Jung, Kristi Romero, Kelly Corbet, et al. “Pre-transplant hepatic steatosis (fatty liver) is associated with chronic graft-vs-host disease but not mortality.” Plos One 15, no. 9 (2020): e0238824. https://doi.org/10.1371/journal.pone.0238824.Full Text Link to Item
-
Williams, Judson B., Asad A. Shah, Shuaiqi Zhang, Sin-Ho Jung, Babatunde Yerokun, Sreekanth Vemulapalli, Peter K. Smith, James S. Gammie, and Jeffrey G. Gaca. “Impact of Microbiological Organism Type on Surgically Managed Endocarditis.” Ann Thorac Surg 108, no. 5 (November 2019): 1325–29. https://doi.org/10.1016/j.athoracsur.2019.04.025.Full Text Link to Item
-
Blum, Kristie A., Mei-Yin Polley, Sin-Ho Jung, Travis J. Dockter, Sarah Anderson, Eric D. Hsi, Nina Wagner-Johnston, et al. “Randomized trial of ofatumumab and bendamustine versus ofatumumab, bendamustine, and bortezomib in previously untreated patients with high-risk follicular lymphoma: CALGB 50904 (Alliance).” Cancer 125, no. 19 (October 1, 2019): 3378–89. https://doi.org/10.1002/cncr.32289.Full Text Link to Item
-
Tang, Yuning J., Jianguo Huang, Hidetoshi Tsushima, Ga I. Ban, Hongyuan Zhang, Kristianne M. Oristian, Vijitha Puviindran, et al. “Tracing Tumor Evolution in Sarcoma Reveals Clonal Origin of Advanced Metastasis.” Cell Rep 28, no. 11 (September 10, 2019): 2837-2850.e5. https://doi.org/10.1016/j.celrep.2019.08.029.Full Text Link to Item
-
Bartlett, Nancy L., Wyndham H. Wilson, Sin-Ho Jung, Eric D. Hsi, Matthew J. Maurer, Levi D. Pederson, Mei-Yin C. Polley, et al. “Dose-Adjusted EPOCH-R Compared With R-CHOP as Frontline Therapy for Diffuse Large B-Cell Lymphoma: Clinical Outcomes of the Phase III Intergroup Trial Alliance/CALGB 50303.” J Clin Oncol 37, no. 21 (July 20, 2019): 1790–99. https://doi.org/10.1200/JCO.18.01994.Full Text Link to Item
-
Jung, Sin-Ho, Sang Ah Chi, and Hyun Joo Ahn. “K-Sample comparisons using propensity analysis.” Biom J 61, no. 3 (May 2019): 698–713. https://doi.org/10.1002/bimj.201800049.Full Text Link to Item
-
Rosenbaum, Cara A., Sin-Ho Jung, Brandelyn Pitcher, Nancy L. Bartlett, Sonali M. Smith, Eric Hsi, Nina Wagner-Johnston, Sachdev P. Thomas, John P. Leonard, and Bruce D. Cheson. “Phase 2 multicentre study of single-agent ofatumumab in previously untreated follicular lymphoma: CALGB 50901 (Alliance).” Br J Haematol 185, no. 1 (April 2019): 53–64. https://doi.org/10.1111/bjh.15768.Full Text Link to Item
-
Yoo, Kwai Han, Su Jin Lee, Jinhyun Cho, Ki Hyeong Lee, Keon Uk Park, Ki Hwan Kim, Eun Kyung Cho, et al. “A Randomized, Open-Label, Phase II Study Comparing Pemetrexed Plus Cisplatin Followed by Maintenance Pemetrexed versus Pemetrexed Alone in Patients with Epidermal Growth Factor Receptor (EGFR)-Mutant Non-small Cell Lung Cancer after Failure of First-Line EGFR Tyrosine Kinase Inhibitor: KCSG-LU12-13.” Cancer Res Treat 51, no. 2 (April 2019): 718–26. https://doi.org/10.4143/crt.2018.324.Full Text Link to Item
-
Pyo, Jeung Hui, Ji Won Kim, Tae Jun Kim, Hyuk Lee, Yang Won Min, Byung-Hoon Min, Jun Haeng Lee, et al. “Physical Activity Protects Against the Risk of Erosive Esophagitis on the Basis of Body Mass Index.” J Clin Gastroenterol 53, no. 2 (February 2019): 102–8. https://doi.org/10.1097/MCG.0000000000000947.Full Text Link to Item
-
Lansigan, Frederick, Ian Barak, Brandelyn Pitcher, Sin-Ho Jung, Bruce D. Cheson, Myron Czuczman, Peter Martin, et al. “The prognostic significance of PFS24 in follicular lymphoma following firstline immunotherapy: A combined analysis of 3 CALGB trials.” Cancer Med 8, no. 1 (January 2019): 165–73. https://doi.org/10.1002/cam4.1918.Full Text Link to Item
-
“Perioperative fresh red blood cell transfusion may negatively affect recipient survival after liver transplantation: Erratum.” Ann Surg 268, no. 6 (December 2018): e98. https://doi.org/10.1097/SLA.0000000000002975.Full Text Link to Item
-
Czuczman, M. S., J. P. Leonard, S. Jung, J. L. Johnson, E. D. Hsi, J. C. Byrd, and B. D. Cheson. “Phase II trial of galiximab (anti-CD80 monoclonal antibody) plus rituximab (CALGB 50402): Follicular Lymphoma International Prognostic Index (FLIPI) score is predictive of upfront immunotherapy responsiveness.” Ann Oncol 29, no. 11 (November 1, 2018): 2271. https://doi.org/10.1093/annonc/mdx812.Full Text Link to Item
-
Wang, Alice, J Matthew Brennan, Shuaiqi Zhang, Sin-Ho Jung, Babatunde Yerokun, Morgan L. Cox, Jeffrey P. Jacobs, et al. “Robotic Mitral Valve Repair in Older Individuals: An Analysis of The Society of Thoracic Surgeons Database.” Ann Thorac Surg 106, no. 5 (November 2018): 1388–93. https://doi.org/10.1016/j.athoracsur.2018.05.074.Full Text Open Access Copy Link to Item
-
Straus, David J., Sin-Ho Jung, Brandelyn Pitcher, Lale Kostakoglu, John C. Grecula, Eric D. Hsi, Heiko Schöder, et al. “CALGB 50604: risk-adapted treatment of nonbulky early-stage Hodgkin lymphoma based on interim PET.” Blood 132, no. 10 (September 6, 2018): 1013–21. https://doi.org/10.1182/blood-2018-01-827246.Full Text Link to Item
-
Tallarico, Michael, Jared C. Foster, Drew Seisler, Jacqueline M. Lafky, Arti Hurria, Aminah Jatoi, Harvey J. Cohen, et al. “Frequency and impact of grade three or four toxicities of novel agents on outcomes of older patients with chronic lymphocytic leukemia and non-Hodgkin lymphoma (alliance A151611).” J Geriatr Oncol 9, no. 4 (July 2018): 321–28. https://doi.org/10.1016/j.jgo.2018.03.018.Full Text Link to Item
-
Kim, Ah Yeong, Dong Hyun Sinn, Woo Kyoung Jeong, Young Kon Kim, Tae Wook Kang, Sang Yun Ha, Chul Keun Park, et al. “Hepatobiliary MRI as novel selection criteria in liver transplantation for hepatocellular carcinoma.” J Hepatol 68, no. 6 (June 2018): 1144–52. https://doi.org/10.1016/j.jhep.2018.01.024.Full Text Link to Item
-
Suresh, Visakha, Junheng Gao, Sin-Ho Jung, Brian Brigman, William Eward, and Detlev Erdmann. “The Role of Reconstructive Surgery After Skeletal and Soft Tissue Sarcoma Resection.” Ann Plast Surg 80, no. 6S Suppl 6 (June 2018): S372–76. https://doi.org/10.1097/SAP.0000000000001419.Full Text Link to Item
-
Parsons, J Kellogg, John P. Pierce, James Mohler, Electra Paskett, Sin-Ho Jung, Michael J. Morris, Eric Small, et al. “Men's Eating and Living (MEAL) study (CALGB 70807 [Alliance]): recruitment feasibility and baseline demographics of a randomized trial of diet in men on active surveillance for prostate cancer.” Bju Int 121, no. 4 (April 2018): 534–39. https://doi.org/10.1111/bju.13890.Full Text Link to Item
-
Brownstein, Jeremy M., Amy J. Wisdom, Katherine D. Castle, Yvonne M. Mowery, Peter Guida, Chang-Lung Lee, Francesco Tommasino, et al. “Characterizing the Potency and Impact of Carbon Ion Therapy in a Primary Mouse Model of Soft Tissue Sarcoma.” Mol Cancer Ther 17, no. 4 (April 2018): 858–68. https://doi.org/10.1158/1535-7163.MCT-17-0965.Full Text Link to Item
-
Sun, Jong-Mu, Ki Hyeong Lee, Bong-Seog Kim, Hoon-Gu Kim, Young Joo Min, Seong Yoon Yi, Hwan Jung Yun, et al. “Pazopanib maintenance after first-line etoposide and platinum chemotherapy in patients with extensive disease small-cell lung cancer: a multicentre, randomised, placebo-controlled Phase II study (KCSG-LU12-07).” Br J Cancer 118, no. 5 (March 6, 2018): 648–53. https://doi.org/10.1038/bjc.2017.465.Full Text Link to Item
-
Yang, Ju-Il, Jong Kyun Lee, Dae Geon Ahn, Joo Kyung Park, Kwang Hyuck Lee, Kyu Taek Lee, Sang Ah Chi, and Sin-Ho Jung. “Predictive Model for Neoplastic Potential of Gallbladder Polyp.” J Clin Gastroenterol 52, no. 3 (March 2018): 273–76. https://doi.org/10.1097/MCG.0000000000000900.Full Text Link to Item
-
Bak, So Hyeon, Hyunjin Park, Ho Yun Lee, Youngwook Kim, Hyung-Lae Kim, Sin-Ho Jung, Hyeseung Kim, Jonghoon Kim, and Keunchil Park. “Imaging genotyping of functional signaling pathways in lung squamous cell carcinoma using a radiomics approach.” Sci Rep 8, no. 1 (February 19, 2018): 3284. https://doi.org/10.1038/s41598-018-21706-1.Full Text Link to Item
-
Jung, Sin-Ho. “Phase II cancer clinical trials for biomarker-guided treatments.” J Biopharm Stat 28, no. 2 (2018): 256–63. https://doi.org/10.1080/10543406.2017.1372777.Full Text Link to Item
-
Jung, Sin-Ho, Ho Yun Lee, and Shein-Chung Chow. “Statistical Methods for Conditional Survival Analysis.” J Biopharm Stat 28, no. 5 (2018): 927–38. https://doi.org/10.1080/10543406.2017.1405012.Full Text Link to Item
-
Lee, Sang Yub, Dongho Hyun, Sung Ki Cho, Sung Wook Shin, Sin-Ho Jung, and Sang Ah Chi. “Iodized Oil Transarterial Chemoembolization and Radiofrequency Ablation for Small Periportal Hepatocellular Carcinoma: Comparison with Nonperiportal Hepatocellular Carcinoma.” Cardiovasc Intervent Radiol 41, no. 1 (January 2018): 120–29. https://doi.org/10.1007/s00270-017-1783-1.Full Text Link to Item
-
Ryan, Sean, Julia Visgauss, David Kerr, Joshua Helmkamp, Nicholas Said, Emily Vinson, Patrick O’Donnell, et al. “The Value of MRI in Distinguishing Subtypes of Lipomatous Extremity Tumors Needs Reassessment in the Era of MDM2 and CDK4 Testing.” Sarcoma 2018 (2018): 1901896. https://doi.org/10.1155/2018/1901896.Full Text Link to Item
-
Jung, Dae Myung, Hyun Joo Ahn, Sin-Ho Jung, Mikyung Yang, Jie Ae Kim, Su Min Shin, and Suyong Jeon. “Blocking the double-lumen orifice versus apneic oxygenation during 1-lung ventilation.” J Thorac Cardiovasc Surg 154, no. 6 (December 2017): 2122–23. https://doi.org/10.1016/j.jtcvs.2017.07.072.Full Text Link to Item
-
Kim, Tae Jun, Jee Eun Kim, Yoon-Ho Choi, Sung Noh Hong, Young-Ho Kim, Dong Kyung Chang, Poong-Lyul Rhee, Min-Ji Kim, Sin-Ho Jung, and Hee Jung Son. “Obesity-related parameters and colorectal adenoma development.” J Gastroenterol 52, no. 12 (December 2017): 1221–29. https://doi.org/10.1007/s00535-017-1319-0.Full Text Link to Item
-
Sun, Jong-Mu, Jae Myung Noh, Dongryul Oh, Hong Kwan Kim, Se-Hoon Lee, Yong Soo Choi, Hongryull Pyo, et al. “Randomized Phase II Trial Comparing Chemoradiotherapy with Chemotherapy for Completely Resected Unsuspected N2-Positive Non-Small Cell Lung Cancer.” J Thorac Oncol 12, no. 12 (December 2017): 1806–13. https://doi.org/10.1016/j.jtho.2017.09.1954.Full Text Link to Item
-
Yeo, Sin Yuin, Young-Sun Kim, Hyo Keun Lim, Hyunchul Rhim, Sin-Ho Jung, and Na Young Hwang. “Uterine fibroids: Influence of "T2-Rim sign" on immediate therapeutic responses to magnetic resonance imaging-guided high-intensity focused ultrasound ablation.” Eur J Radiol 97 (December 2017): 21–30. https://doi.org/10.1016/j.ejrad.2017.10.006.Full Text Link to Item
-
Kwon, H. J., D. H. Kim, H. R. Jang, S. -. H. Jung, D. H. Han, H. H. Sung, J. B. Park, et al. “Predictive Factors of Renal Adaptation After Nephrectomy in Kidney Donors.” Transplant Proc 49, no. 9 (November 2017): 1999–2006. https://doi.org/10.1016/j.transproceed.2017.09.024.Full Text Link to Item
-
Martin, P., S. -. H. Jung, B. Pitcher, N. L. Bartlett, K. A. Blum, T. Shea, E. D. Hsi, et al. “A phase II trial of lenalidomide plus rituximab in previously untreated follicular non-Hodgkin's lymphoma (NHL): CALGB 50803 (Alliance).” Ann Oncol 28, no. 11 (November 1, 2017): 2806–12. https://doi.org/10.1093/annonc/mdx496.Full Text Link to Item
-
McCarthy, Philip L., Sarah A. Holstein, Maria Teresa Petrucci, Paul G. Richardson, Cyrille Hulin, Patrizia Tosi, Sara Bringhen, et al. “Lenalidomide Maintenance After Autologous Stem-Cell Transplantation in Newly Diagnosed Multiple Myeloma: A Meta-Analysis.” J Clin Oncol 35, no. 29 (October 10, 2017): 3279–89. https://doi.org/10.1200/JCO.2017.72.6679.Full Text Link to Item
-
Holstein, Sarah A., Sin-Ho Jung, Paul G. Richardson, Craig C. Hofmeister, David D. Hurd, Hani Hassoun, Sergio Giralt, et al. “Updated analysis of CALGB (Alliance) 100104 assessing lenalidomide versus placebo maintenance after single autologous stem-cell transplantation for multiple myeloma: a randomised, double-blind, phase 3 trial.” Lancet Haematol 4, no. 9 (September 2017): e431–42. https://doi.org/10.1016/S2352-3026(17)30140-0.Full Text Link to Item
-
Jung, Sin-Ho. “Design of Phase II Non-inferiority Trials.” Contemp Clin Trials Commun 7 (September 2017): 23–27. https://doi.org/10.1016/j.conctc.2017.04.008.Full Text Link to Item
-
Kim, Young-Sun, Tae-Joong Kim, Hyo Keun Lim, Hyunchul Rhim, Sin-Ho Jung, Joong Hyun Ahn, Jeong-Won Lee, and Byoung-Gie Kim. “Preservation of the endometrial enhancement after magnetic resonance imaging-guided high-intensity focused ultrasound ablation of submucosal uterine fibroids.” Eur Radiol 27, no. 9 (September 2017): 3956–65. https://doi.org/10.1007/s00330-017-4765-4.Full Text Link to Item
-
Kim, Mimi, Tae Wook Kang, Woo Kyoung Jeong, Young Kon Kim, Seong Hyun Kim, Jong Man Kim, Dong Hyun Sinn, Min-Ji Kim, and Sin-Ho Jung. “Gadoxetic acid-enhanced magnetic resonance imaging characteristics of hepatocellular carcinoma occurring in liver transplants.” Eur Radiol 27, no. 8 (August 2017): 3117–27. https://doi.org/10.1007/s00330-016-4662-2.Full Text Link to Item
-
Jung, Dae Myung, Hyun Joo Ahn, Sin-Ho Jung, Mikyung Yang, Jie Ae Kim, Su Min Shin, and Suyong Jeon. “Apneic oxygen insufflation decreases the incidence of hypoxemia during one-lung ventilation in open and thoracoscopic pulmonary lobectomy: A randomized controlled trial.” The Journal of Thoracic and Cardiovascular Surgery 154, no. 1 (July 2017): 360–66. https://doi.org/10.1016/j.jtcvs.2017.02.054.Full Text
-
Kim, Hosu, Tae Hyuk Kim, Jun-Ho Choe, Jung-Han Kim, Jee Soo Kim, Young Lyun Oh, Soo Yeon Hahn, et al. “Patterns of Initial Recurrence in Completely Resected Papillary Thyroid Carcinoma.” Thyroid 27, no. 7 (July 2017): 908–14. https://doi.org/10.1089/thy.2016.0648.Full Text Link to Item
-
Sohn, Won, Ju-Yeon Cho, Ji Hoon Kim, Jung Il Lee, Hyung Joon Kim, Min-Ah Woo, Sin-Ho Jung, and Yong-Han Paik. “Risk score model for the development of hepatocellular carcinoma in treatment-naïve patients receiving oral antiviral treatment for chronic hepatitis B.” Clin Mol Hepatol 23, no. 2 (June 2017): 170–78. https://doi.org/10.3350/cmh.2016.0086.Full Text Link to Item
-
Kim, Wooil, Ho Yun Lee, Sin-Ho Jung, Min-Ah Woo, Hong Kwan Kim, Yong Soo Choi, Jhingook Kim, et al. “Dynamic prognostication using conditional survival analysis for patients with operable lung adenocarcinoma.” Oncotarget 8, no. 19 (May 9, 2017): 32201–11. https://doi.org/10.18632/oncotarget.12920.Full Text Link to Item
-
Pyo, Jeung Hui, Hyuk Lee, Byung-Hoon Min, Jun Haeng Lee, Min Gew Choi, Jun Ho Lee, Tae Sung Sohn, et al. “Early gastric cancer with a mixed-type Lauren classification is more aggressive and exhibits greater lymph node metastasis.” J Gastroenterol 52, no. 5 (May 2017): 594–601. https://doi.org/10.1007/s00535-016-1254-5.Full Text Link to Item
-
Smith, Sonali M., Brandelyn N. Pitcher, Sin-Ho Jung, Nancy L. Bartlett, Nina Wagner-Johnston, Steven I. Park, Kristy L. Richards, et al. “Safety and tolerability of idelalisib, lenalidomide, and rituximab in relapsed and refractory lymphoma: the Alliance for Clinical Trials in Oncology A051201 and A051202 phase 1 trials.” Lancet Haematol 4, no. 4 (April 2017): e176–82. https://doi.org/10.1016/S2352-3026(17)30028-5.Full Text Link to Item
-
Kim, Mijin, Young Nam Kim, Won Gu Kim, Suyeon Park, Hyemi Kwon, Min Ji Jeon, Hyeon Seon Ahn, et al. “Optimal cut-off age in the TNM Staging system of differentiated thyroid cancer: is 55 years better than 45 years?” Clin Endocrinol (Oxf) 86, no. 3 (March 2017): 438–43. https://doi.org/10.1111/cen.13254.Full Text Link to Item
-
Lee, J. Y., J. M. Sun, D. Oh, S. H. Lim, S. Chi, S. H. Lee, S. H. Jung, M. J. Ahn, Y. C. Ahn, and K. Park. “A phase II trial of concurrent chemoradiotherapy with weekly docetaxel plus cisplatin treatment for unresectable locally advanced head and neck cancer.” Radiotherapy and Oncology 122, no. 2 (February 1, 2017): 217–23. https://doi.org/10.1016/j.radonc.2016.09.015.Full Text
-
Kim, S. S., T. W. Kang, K. D. Song, S. K. Cho, M. W. Lee, H. Rhim, D. H. Sinn, and S. -. H. Jung. “Radiofrequency ablation and transarterial chemoembolisation as first-line treatment for recurrent hepatocellular carcinoma or isolated intrahepatic recurrent hepatocellular carcinoma in transplanted livers.” Clin Radiol 72, no. 2 (February 2017): 141–49. https://doi.org/10.1016/j.crad.2016.09.008.Full Text Link to Item
-
Ahn, J. S., D. H. Sinn, Y. W. Min, S. N. Hong, H. S. Kim, S. -. H. Jung, S. Gu, et al. “Non-alcoholic fatty liver diseases and risk of colorectal neoplasia.” Alimentary Pharmacology & Therapeutics 45, no. 2 (January 2017): 345–53. https://doi.org/10.1111/apt.13866.Full Text
-
Hong, Sung Noh, Hee Jung Son, Sun Kyu Choi, Dong Kyung Chang, Young-Ho Kim, Sin-Ho Jung, and Poong-Lyul Rhee. “A prediction model for advanced colorectal neoplasia in an asymptomatic screening population.” Plos One 12, no. 8 (2017): e0181040. https://doi.org/10.1371/journal.pone.0181040.Full Text Link to Item
-
Kwak, Minjung, and Sin-Ho Jung. “Optimal two-stage log-rank test for randomized phase II clinical trials.” J Biopharm Stat 27, no. 4 (2017): 639–58. https://doi.org/10.1080/10543406.2016.1167073.Full Text Link to Item
-
Park, Charny, Junhun Cho, Jeeyun Lee, So Young Kang, Ji Yeong An, Min Gew Choi, Jun Ho Lee, et al. “Host immune response index in gastric cancer identified by comprehensive analyses of tumor immunity.” Oncoimmunology 6, no. 11 (2017): e1356150. https://doi.org/10.1080/2162402X.2017.1356150.Full Text Link to Item
-
Lee, S. H., W. S. Sim, G. E. Kim, H. C. Kim, J. H. Jun, J. Y. Lee, B. S. Shin, et al. “Randomized trial of subfascial infusion of ropivacaine for early recovery in laparoscopic colorectal cancer surgery.” Korean Journal of Anesthesiology 69, no. 6 (December 1, 2016): 604–13. https://doi.org/10.4097/kjae.2016.69.6.604.Full Text
-
Pyo, Jeung Hui, Soomin Ahn, Hyuk Lee, Byung-Hoon Min, Jun Haeng Lee, Sang Goon Shim, Min Gew Choi, et al. “Clinicopathological Features and Prognosis of Mixed-Type T1a Gastric Cancer Based on Lauren's Classification.” Ann Surg Oncol 23, no. Suppl 5 (December 2016): 784–91. https://doi.org/10.1245/s10434-016-5549-9.Full Text Link to Item
-
Kim, Jieun, Su Mi Kim, Man Ho Ha, Jeong Eun Seo, Min-Gew Choi, Jun Ho Lee, Tae Sung Sohn, Sung Kim, Sin-Ho Jung, and Jae Moon Bae. “Does the interval of screening endoscopy affect survival in gastric cancer patients?: A cross-sectional study.” Medicine (Baltimore) 95, no. 49 (December 2016): e5490. https://doi.org/10.1097/MD.0000000000005490.Full Text Link to Item
-
Pyo, Jeung Hui, Cheol Min Shin, Hyuk Lee, Byung-Hoon Min, Jun Haeng Lee, Su Mi Kim, Min Gew Choi, et al. “A Risk-prediction Model Based on Lymph-node Metastasis for Incorporation Into a Treatment Algorithm for Signet Ring Cell-type Intramucosal Gastric Cancer.” Ann Surg 264, no. 6 (December 2016): 1038–43. https://doi.org/10.1097/SLA.0000000000001602.Full Text Link to Item
-
Pyo, Jeung Hui, Sung Noh Hong, Byung-Hoon Min, Jun Haeng Lee, Dong Kyung Chang, Poong-Lyul Rhee, Jae Jun Kim, et al. “Evaluation of the risk factors associated with rectal neuroendocrine tumors: a big data analytic study from a health screening center.” J Gastroenterol 51, no. 12 (December 2016): 1112–21. https://doi.org/10.1007/s00535-016-1198-9.Full Text Link to Item
-
Ujjani, Chaitra S., Sin-Ho Jung, Brandelyn Pitcher, Peter Martin, Steven I. Park, Kristie A. Blum, Sonali M. Smith, et al. “Phase 1 trial of rituximab, lenalidomide, and ibrutinib in previously untreated follicular lymphoma: Alliance A051103.” Blood 128, no. 21 (November 24, 2016): 2510–16. https://doi.org/10.1182/blood-2016-06-718106.Full Text Link to Item
-
Kang, Tae Wook, Hyunchul Rhim, Jisun Lee, Kyoung Doo Song, Min Woo Lee, Young-Sun Kim, Hyo Keun Lim, et al. “Magnetic resonance imaging with gadoxetic acid for local tumour progression after radiofrequency ablation in patients with hepatocellular carcinoma.” Eur Radiol 26, no. 10 (October 2016): 3437–46. https://doi.org/10.1007/s00330-015-4190-5.Full Text Link to Item
-
Kim, Kwang Min, Dong Hyun Sinn, Sin-Ho Jung, Geum-Youn Gwak, Yong-Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, and Seung Woon Paik. “The recommended treatment algorithms of the BCLC and HKLC staging systems: does following these always improve survival rates for HCC patients?” Liver Int 36, no. 10 (October 2016): 1490–97. https://doi.org/10.1111/liv.13107.Full Text Link to Item
-
Kim, Tae Jun, Hyuk Lee, Yang Won Min, Byung-Hoon Min, Jun Haeng Lee, Hee Jung Son, Poong-Lyul Rhee, Sun-Young Baek, Sin-Ho Jung, and Jae J. Kim. “Diabetic biomarkers and the risk of proximal or distal gastric cancer.” J Gastroenterol Hepatol 31, no. 10 (October 2016): 1705–10. https://doi.org/10.1111/jgh.13329.Full Text Link to Item
-
Lee, Keol, Dong Hyun Sinn, Geum-Youn Gwak, Hyun Chin Cho, Sin-Ho Jung, Yong-Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, and Seung Woon Paik. “Prediction of the Risk of Hepatocellular Carcinoma in Chronic Hepatitis C Patients after Sustained Virological Response by Aspartate Aminotransferase to Platelet Ratio Index.” Gut Liver 10, no. 5 (September 15, 2016): 796–802. https://doi.org/10.5009/gnl15368.Full Text Link to Item
-
Ahn, Soomin, Jeeyun Lee, Mineui Hong, Seung Tae Kim, Se Hoon Park, Min Gew Choi, Jun-Ho Lee, et al. “FGFR2 in gastric cancer: protein overexpression predicts gene amplification and high H-index predicts poor survival.” Mod Pathol 29, no. 9 (September 2016): 1095–1103. https://doi.org/10.1038/modpathol.2016.96.Full Text Link to Item
-
Ahn, Soomin, Mineui Hong, Michael Van Vrancken, You Jeong Lyou, Seung Tae Kim, Se Hoon Park, Won Ki Kang, et al. “A nCounter CNV Assay to Detect HER2 Amplification: A Correlation Study with Immunohistochemistry and In Situ Hybridization in Advanced Gastric Cancer.” Mol Diagn Ther 20, no. 4 (August 2016): 375–83. https://doi.org/10.1007/s40291-016-0205-4.Full Text Link to Item
-
Sohn, Won, Tae Wook Kang, Sun-Kyu Choi, Sin-Ho Jung, Min Woo Lee, Hyo Keun Lim, Ju-Yeon Cho, et al. “Effect of oral antiviral treatment on long-term outcomes of radiofrequency ablation therapy for hepatitis B virus-related hepatocellular carcinoma.” Oncotarget 7, no. 30 (July 26, 2016): 47794–807. https://doi.org/10.18632/oncotarget.10026.Full Text Link to Item
-
Kim, Do Hee, Hee Jin Kwon, Sang A. Ji, Hye Ryoun Jang, Sin-Ho Jung, Jung-Han Kim, Jae Hyeon Kim, et al. “Risk factors for renal impairment revealed after unilateral adrenalectomy in patients with primary aldosteronism.” Medicine (Baltimore) 95, no. 27 (July 2016): e3930. https://doi.org/10.1097/MD.0000000000003930.Full Text Link to Item
-
Kang, Tae Wook, Min Woo Lee, Dongil Choi, Chansik An, Myeong-Jin Kim, Ijin Joo, So Jung Lee, et al. “Safety of Percutaneous Biopsy for Hepatic Angiosarcoma: Results of a Multicenter Korean Survey.” Journal of Vascular and Interventional Radiology : Jvir 27, no. 6 (June 2016): 846–51. https://doi.org/10.1016/j.jvir.2016.01.148.Full Text
-
Park, Hong Suk, Young Soo Do, Kwang Bo Park, Keon-Ha Kim, Sook Young Woo, Sin-Ho Jung, Dong-Ik Kim, et al. “Clinical outcome and predictors of treatment response in foam sodium tetradecyl sulfate sclerotherapy of venous malformations.” Eur Radiol 26, no. 5 (May 2016): 1301–10. https://doi.org/10.1007/s00330-015-3931-9.Full Text Link to Item
-
Lee, Hee Young, Sung Mok Kim, Kyung Soo Lee, Seung Woo Park, Myung Jin Chung, Hyoun Cho, Jung Im Jung, Hye Won Jang, Sin-Ho Jung, and Juna Goo. “Quantification of Aortic Valve Calcifications Detected During Lung Cancer-Screening CT Helps Stratify Subjects Necessitating Echocardiography for Aortic Stenosis Diagnosis.” Medicine (Baltimore) 95, no. 19 (May 2016): e3710. https://doi.org/10.1097/MD.0000000000003710.Full Text Link to Item
-
Kim, Seung Tae, Jeeyun Lee, Su Jin Lee, Se Hoon Park, Sin-Ho Jung, Young Suk Park, Ho Yeong Lim, Won Ki Kang, and Joon Oh Park. “Prospective phase II trial of pazopanib plus CapeOX (capecitabine and oxaliplatin) in previously untreated patients with advanced gastric cancer.” Oncotarget 7, no. 17 (April 26, 2016): 24088–96. https://doi.org/10.18632/oncotarget.8175.Full Text Link to Item
-
Huh, Jung Wook, Sung Chun Kim, Insuk Sohn, Sin-Ho Jung, and Hee Cheol Kim. “Serum protein profiling using an aptamer array predicts clinical outcomes of stage IIA colon cancer: A leave-one-out crossvalidation.” Oncotarget 7, no. 13 (March 29, 2016): 16338–48. https://doi.org/10.18632/oncotarget.7488.Full Text Link to Item
-
Ahn, Jong-Hwa, Sung Mok Kim, Sung-Ji Park, Dong Seop Jeong, Min-Ah Woo, Sin-Ho Jung, Sang-Chol Lee, et al. “Coronary Microvascular Dysfunction as a Mechanism of Angina in Severe AS: Prospective Adenosine-Stress CMR Study.” J Am Coll Cardiol 67, no. 12 (March 29, 2016): 1412–22. https://doi.org/10.1016/j.jacc.2016.01.013.Full Text Link to Item
-
Kim, Seok Jin, Dok Hyun Yoon, Arnaud Jaccard, Wee Joo Chng, Soon Thye Lim, Huangming Hong, Yong Park, et al. “A prognostic index for natural killer cell lymphoma after non-anthracycline-based treatment: a multicentre, retrospective analysis.” Lancet Oncol 17, no. 3 (March 2016): 389–400. https://doi.org/10.1016/S1470-2045(15)00533-1.Full Text Link to Item
-
Shin, Jung-Ho, Eun Hee Koo, Sung Hae Ha, Ji Hyeon Park, Hye Ryoun Jang, Jung Eun Lee, Jae-Berm Park, et al. “The impact of slow graft function on graft outcome is comparable to delayed graft function in deceased donor kidney transplantation.” Int Urol Nephrol 48, no. 3 (March 2016): 431–39. https://doi.org/10.1007/s11255-015-1163-1.Full Text Link to Item
-
Ham, J. S., S. J. Kim, J. Y. Choi, S. H. Hyun, S. -. K. Choi, H. S. Kim, S. H. Lim, et al. “The prognostic value of interim and end-of-treatment PET/CT in patients with newly diagnosed peripheral T-cell lymphoma.” Blood Cancer J 6, no. 2 (February 12, 2016): e395. https://doi.org/10.1038/bcj.2016.2.Full Text Link to Item
-
Lee, Ji Yun, Xu Qing, Wei Xiumin, Bai Yali, Sangah Chi, So Hyeon Bak, Ho Yun Lee, et al. “Longitudinal monitoring of EGFR mutations in plasma predicts outcomes of NSCLC patients treated with EGFR TKIs: Korean Lung Cancer Consortium (KLCC-12-02).” Oncotarget 7, no. 6 (February 9, 2016): 6984–93. https://doi.org/10.18632/oncotarget.6874.Full Text Link to Item
-
Lee, Ji Yun, Jong-Mu Sun, Dong Ryul Oh, Sung Hee Lim, Juna Goo, Se-Hoon Lee, Sung-Bae Kim, et al. “Comparison of weekly versus triweekly cisplatin delivered concurrently with radiation therapy in patients with locally advanced nasopharyngeal cancer: A multicenter randomized phase II trial (KCSG-HN10-02).” Radiother Oncol 118, no. 2 (February 2016): 244–50. https://doi.org/10.1016/j.radonc.2015.11.030.Full Text Link to Item
-
Pyo, Jeung Hui, Hyuk Lee, Byung-Hoon Min, Jun Haeng Lee, Min Gew Choi, Jun Ho Lee, Tae Sung Sohn, et al. “A Risk Prediction Model Based on Lymph-Node Metastasis in Poorly Differentiated-Type Intramucosal Gastric Cancer.” Plos One 11, no. 5 (2016): e0156207. https://doi.org/10.1371/journal.pone.0156207.Full Text Link to Item
-
Kim, Young-sun, Hyo Keun Lim, Min Jung Park, Hyunchul Rhim, Sin-Ho Jung, Insuk Sohn, Tae-Joong Kim, and Bilgin Keserci. “Screening Magnetic Resonance Imaging-Based Prediction Model for Assessing Immediate Therapeutic Response to Magnetic Resonance Imaging-Guided High-Intensity Focused Ultrasound Ablation of Uterine Fibroids.” Invest Radiol 51, no. 1 (January 2016): 15–24. https://doi.org/10.1097/RLI.0000000000000199.Full Text Link to Item
-
Lim, S. H., M. Hong, S. Ahn, Y. -. L. Choi, K. -. M. Kim, D. Oh, Y. C. Ahn, et al. “Changes in tumour expression of programmed death-ligand 1 after neoadjuvant concurrent chemoradiotherapy in patients with squamous oesophageal cancer.” Eur J Cancer 52 (January 2016): 1–9. https://doi.org/10.1016/j.ejca.2015.09.019.Full Text Link to Item
-
Shin, Jung-Ho, Hee Jin Kwon, Hye Ryoun Jang, Jung Eun Lee, Geum-Youn Gwak, Wooseong Huh, Sin-Ho Jung, et al. “Risk Factors for Renal Functional Decline in Chronic Hepatitis B Patients Receiving Oral Antiviral Agents.” Medicine (Baltimore) 95, no. 1 (January 2016): e2400. https://doi.org/10.1097/MD.0000000000002400.Full Text Link to Item
-
Shin, Jung-ho, Jung Eun Lee, Ji Hyeon Park, Sharon Lim, Hye Ryoun Jang, Ghee Young Kwon, Wooseong Huh, et al. “The effects of cytotoxic therapy in progressive IgA nephropathy.” Ann Med 48, no. 3 (2016): 171–81. https://doi.org/10.3109/07853890.2016.1153805.Full Text Link to Item
-
Lee, Geun Dong, Seung Eun Lee, Kyoung-Mee Kim, Yong-Hee Kim, Joong Hyun Ahn, Sinho Jung, Yoon-La Choi, Hyeong Ryul Kim, Seung-Il Park, and Young Mog Shim. “New 3-Tiered Circumferential Resection Margin Criteria in Esophageal Squamous Cell Carcinoma.” Ann Surg 262, no. 6 (December 2015): 965–71. https://doi.org/10.1097/SLA.0000000000001039.Full Text Link to Item
-
Lim, S. H., T. W. Kim, Y. S. Hong, S. -. W. Han, K. -. H. Lee, H. J. Kang, I. G. Hwang, et al. “A randomised, double-blind, placebo-controlled multi-centre phase III trial of XELIRI/FOLFIRI plus simvastatin for patients with metastatic colorectal cancer.” Br J Cancer 113, no. 10 (November 17, 2015): 1421–26. https://doi.org/10.1038/bjc.2015.371.Full Text Link to Item
-
Ahn, Sangjeong, Soomin Ahn, Michael Van Vrancken, Minju Lee, Sang Yun Ha, Hyuk Lee, Byung-Hoon Min, et al. “Ideal number of biopsy tumor fragments for predicting HER2 status in gastric carcinoma resection specimens.” Oncotarget 6, no. 35 (November 10, 2015): 38372–80. https://doi.org/10.18632/oncotarget.5368.Full Text Link to Item
-
Lee, Junggyu, Dong Hyun Sinn, Jung Hee Kim, Geum-Youn Gwak, Hye Seung Kim, Sin-Ho Jung, Yong-Han Paik, et al. “Hepatocellular Carcinoma Risk of Compensated Cirrhosis Patients with Elevated HBV DNA Levels according to Serum Aminotransferase Levels.” J Korean Med Sci 30, no. 11 (November 2015): 1618–24. https://doi.org/10.3346/jkms.2015.30.11.1618.Full Text Link to Item
-
Leonard, John P., Sin-Ho Jung, Jeffrey Johnson, Brandelyn N. Pitcher, Nancy L. Bartlett, Kristie A. Blum, Myron Czuczman, Jeffrey K. Giguere, and Bruce D. Cheson. “Randomized Trial of Lenalidomide Alone Versus Lenalidomide Plus Rituximab in Patients With Recurrent Follicular Lymphoma: CALGB 50401 (Alliance).” J Clin Oncol 33, no. 31 (November 1, 2015): 3635–40. https://doi.org/10.1200/JCO.2014.59.9258.Full Text Link to Item
-
Kim, Seung Tae, Jeeyun Lee, Mineui Hong, Kyunghee Park, Joon Oh Park, TaeJin Ahn, Se Hoon Park, et al. “The NEXT-1 (Next generation pErsonalized tX with mulTi-omics and preclinical model) trial: prospective molecular screening trial of metastatic solid cancer patients, a feasibility analysis.” Oncotarget 6, no. 32 (October 20, 2015): 33358–68. https://doi.org/10.18632/oncotarget.5188.Full Text Link to Item
-
Park, Se Hoon, Tae Sung Sohn, Jeeyun Lee, Do Hoon Lim, Min Eui Hong, Kyoung-Mee Kim, Insuk Sohn, et al. “Phase III Trial to Compare Adjuvant Chemotherapy With Capecitabine and Cisplatin Versus Concurrent Chemoradiotherapy in Gastric Cancer: Final Report of the Adjuvant Chemoradiotherapy in Stomach Tumors Trial, Including Survival and Subset Analyses.” J Clin Oncol 33, no. 28 (October 1, 2015): 3130–36. https://doi.org/10.1200/JCO.2014.58.3930.Full Text Link to Item
-
Lee, S., J. Lim, I. Sohn, S. H. Jung, and C. K. Park. “Two sample test for high-dimensional partially paired data.” Journal of Applied Statistics 42, no. 9 (September 2, 2015): 1946–61. https://doi.org/10.1080/02664763.2015.1014890.Full Text
-
Song, Kyoung Doo, Seong Hyun Kim, Hyo Keun Lim, Sin-Ho Jung, Insuk Sohn, and Hyung Sik Kim. “Subcentimeter hypervascular nodule with typical imaging findings of hepatocellular carcinoma in patients with history of hepatocellular carcinoma: natural course on serial gadoxetic acid-enhanced MRI and diffusion-weighted imaging.” Eur Radiol 25, no. 9 (September 2015): 2789–96. https://doi.org/10.1007/s00330-015-3680-9.Full Text Link to Item
-
Ahn, Jin Seok, Yong Chan Ahn, Joo-Hang Kim, Chang Geol Lee, Eun Kyung Cho, Kyu Chan Lee, Ming Chen, et al. “Multinational Randomized Phase III Trial With or Without Consolidation Chemotherapy Using Docetaxel and Cisplatin After Concurrent Chemoradiation in Inoperable Stage III Non-Small-Cell Lung Cancer: KCSG-LU05-04.” J Clin Oncol 33, no. 24 (August 20, 2015): 2660–66. https://doi.org/10.1200/JCO.2014.60.0130.Full Text Link to Item
-
Sun, Jong-Mu, Jin Seok Ahn, Sin-Ho Jung, Jiyu Sun, Sang Yun Ha, Joungho Han, Keunchil Park, and Myung-Ju Ahn. “Pemetrexed Plus Cisplatin Versus Gemcitabine Plus Cisplatin According to Thymidylate Synthase Expression in Nonsquamous Non-Small-Cell Lung Cancer: A Biomarker-Stratified Randomized Phase II Trial.” J Clin Oncol 33, no. 22 (August 1, 2015): 2450–56. https://doi.org/10.1200/JCO.2014.59.9324.Full Text Link to Item
-
Lugogo, N. L., J. W. Hollingsworth, D. L. Howell, L. G. Que, D. Francisco, T. D. Church, E. N. Potts-Kant, J. L. Ingram, Y. Wang, and S. H. Jung. “Alveolar Macrophages from Overweight/Obese Subjects with Asthma Demonstrate a Proinflammatory Phenotype (Retraction of vol 186, pg 404, 2012).” American Journal of Respiratory and Critical Care Medicine 192, no. 2 (July 15, 2015): 264–264.Link to Item
-
Kwak, Minjung, Sang-Won Um, and Sin-Ho Jung. “Comparison of operational characteristics for binary tests with clustered data.” Stat Med 34, no. 15 (July 10, 2015): 2325–33. https://doi.org/10.1002/sim.6485.Full Text Link to Item
-
Cho, Jae-Keun, Gil-Joon Lee, Keun-Ik Yi, Kyu-Sup Cho, Nayeon Choi, Jong Se Kim, Hakyoung Kim, et al. “Development and external validation of nomograms predictive of response to radiation therapy and overall survival in nasopharyngeal cancer patients.” Eur J Cancer 51, no. 10 (July 2015): 1303–11. https://doi.org/10.1016/j.ejca.2015.04.003.Full Text Link to Item
-
Lee, Kwang Hyuck, Jong Kyun Lee, Dong Wook Choi, In-Gu Do, Insuk Sohn, Kee-Taek Jang, Sin-Ho Jung, Jin Seok Heo, Seong Ho Choi, and Kyu Taek Lee. “Postoperative prognosis prediction of pancreatic cancer with seven microRNAs.” Pancreas 44, no. 5 (July 2015): 764–68. https://doi.org/10.1097/MPA.0000000000000346.Full Text Link to Item
-
Park, Yeon Hee, Kyung Hae Jung, Seock-Ah Im, Joo Hyuk Sohn, Jungsil Ro, Jin-Hee Ahn, Sung-Bae Kim, et al. “Quality of life (QoL) in metastatic breast cancer patients with maintenance paclitaxel plus gemcitabine (PG) chemotherapy: results from phase III, multicenter, randomized trial of maintenance chemotherapy versus observation (KCSG-BR07-02).” Breast Cancer Res Treat 152, no. 1 (July 2015): 77–85. https://doi.org/10.1007/s10549-015-3450-z.Full Text Link to Item
-
Cristescu, Razvan, Jeeyun Lee, Michael Nebozhyn, Kyoung-Mee Kim, Jason C. Ting, Swee Seong Wong, Jiangang Liu, et al. “Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes.” Nat Med 21, no. 5 (May 2015): 449–56. https://doi.org/10.1038/nm.3850.Full Text Link to Item
-
Jung, Sin-Ho. “Statistical issues for design and analysis of single-arm multi-stage phase II cancer clinical trials.” Contemporary Clinical Trials 42 (May 2015): 9–17. https://doi.org/10.1016/j.cct.2015.02.007.Full Text
-
Park, Yeon Hee, Hae Hyun Jung, In-Gu Do, Eun Yoon Cho, Insuk Sohn, Sin-Ho Jung, Won Ho Kil, et al. “A seven-gene signature can predict distant recurrence in patients with triple-negative breast cancers who receive adjuvant chemotherapy following surgery.” Int J Cancer 136, no. 8 (April 15, 2015): 1976–84. https://doi.org/10.1002/ijc.29233.Full Text Link to Item
-
Lim, S. H., J. Y. Lee, M. -. Y. Lee, H. S. Kim, J. Lee, J. -. M. Sun, J. S. Ahn, et al. “A randomized phase III trial of stereotactic radiosurgery (SRS) versus observation for patients with asymptomatic cerebral oligo-metastases in non-small-cell lung cancer.” Ann Oncol 26, no. 4 (April 2015): 762–68. https://doi.org/10.1093/annonc/mdu584.Full Text Link to Item
-
Morrison, Vicki A., Sin-Ho Jung, Jeffrey Johnson, Ann LaCasce, Kristie A. Blum, Nancy L. Bartlett, Brandelyn N. Pitcher, and Bruce D. Cheson. “Therapy with bortezomib plus lenalidomide for relapsed/refractory mantle cell lymphoma: final results of a phase II trial (CALGB 50501).” Leuk Lymphoma 56, no. 4 (April 2015): 958–64. https://doi.org/10.3109/10428194.2014.938333.Full Text Link to Item
-
Park, Sungmin, Min-Gew Choi, Kyoung-Mee Kim, Hye Seung Kim, Sin-Ho Jung, Jun Ho Lee, Jae Hyung Noh, Tae Sung Sohn, Jae Moon Bae, and Sung Kim. “Lymphoepithelioma-like carcinoma: a distinct type of gastric cancer.” J Surg Res 194, no. 2 (April 2015): 458–63. https://doi.org/10.1016/j.jss.2014.12.005.Full Text Link to Item
-
Hong, Jung Yong, Min Eui Hong, Moon Ki Choi, Wonjin Chang, In-Gu Do, Ji-Suk Jo, Sin-Ho Jung, et al. “The clinical significance of activated p-AKT expression in peripheral T-cell lymphoma.” Anticancer Research 35, no. 4 (April 2015): 2465–74.
-
Hong, J. Y., D. H. Yoon, C. Suh, J. Huh, I. -. G. Do, I. Sohn, J. Jo, et al. “EBV-positive diffuse large B-cell lymphoma in young adults: is this a distinct disease entity?” Ann Oncol 26, no. 3 (March 2015): 548–55. https://doi.org/10.1093/annonc/mdu556.Full Text Link to Item
-
Kim, Seok Jin, Joon Young Choi, Seung Hyup Hyun, Chang-Seok Ki, Dongryul Oh, Yong Chan Ahn, Young Hyeh Ko, et al. “Risk stratification on the basis of Deauville score on PET-CT and the presence of Epstein-Barr virus DNA after completion of primary treatment for extranodal natural killer/T-cell lymphoma, nasal type: a multicentre, retrospective analysis.” Lancet Haematol 2, no. 2 (February 2015): e66–74. https://doi.org/10.1016/S2352-3026(15)00002-2.Full Text Link to Item
-
Son, Dae-Soon, DongHyuk Lee, Kyusang Lee, Sin-Ho Jung, Taejin Ahn, Eunjin Lee, Insuk Sohn, et al. “Practical approach to determine sample size for building logistic prediction models using high-throughput data.” J Biomed Inform 53 (February 2015): 355–62. https://doi.org/10.1016/j.jbi.2014.12.010.Full Text Link to Item
-
Um, Sang-Won, Hong Kwan Kim, Sin-Ho Jung, Joungho Han, Kyung Jong Lee, Hye Yun Park, Yong Soo Choi, et al. “Endobronchial ultrasound versus mediastinoscopy for mediastinal nodal staging of non-small-cell lung cancer.” J Thorac Oncol 10, no. 2 (February 2015): 331–37. https://doi.org/10.1097/JTO.0000000000000388.Full Text Link to Item
-
Kang, Kyung A., Young Kon Kim, EunJu Kim, Woo Kyoung Jeong, Dongil Choi, Won Jae Lee, Sin-Ho Jung, and Sun-Young Baek. “T2-Weighted Liver MRI Using the MultiVane Technique at 3T: Comparison with Conventional T2-Weighted MRI.” Korean J Radiol 16, no. 5 (2015): 1038–46. https://doi.org/10.3348/kjr.2015.16.5.1038.Full Text Link to Item
-
Kwak, Minjung, Jinseog Kim, and Sin-Ho Jung. “Optimal estimation for regression models on τ-year survival probability.” J Biopharm Stat 25, no. 3 (2015): 539–47. https://doi.org/10.1080/10543406.2014.923726.Full Text Link to Item
-
Park, Ji Hyeon, Do Hee Kim, Hye Ryoun Jang, Min-Ji Kim, Sin-Ho Jung, Jung Eun Lee, Wooseong Huh, Yoon-Goo Kim, Dae Joong Kim, and Ha Young Oh. “Clinical relevance of procalcitonin and C-reactive protein as infection markers in renal impairment: a cross-sectional study.” Crit Care 18, no. 6 (November 19, 2014): 640. https://doi.org/10.1186/s13054-014-0640-8.Full Text Link to Item
-
Du, Juan, Sandra Lopez-Verges, Brandelyn N. Pitcher, Jeffrey Johnson, Sin-Ho Jung, Lili Zhou, Katharine Hsu, et al. “CALGB 150905 (Alliance): rituximab broadens the antilymphoma response by activating unlicensed NK cells.” Cancer Immunol Res 2, no. 9 (September 2014): 878–89. https://doi.org/10.1158/2326-6066.CIR-13-0158.Full Text Link to Item
-
Parsons, J Kellogg, John P. Pierce, James Mohler, Electra Paskett, Sin-Ho Jung, Peter Humphrey, John R. Taylor, et al. “A randomized trial of diet in men with early stage prostate cancer on active surveillance: rationale and design of the Men's Eating and Living (MEAL) Study (CALGB 70807 [Alliance]).” Contemp Clin Trials 38, no. 2 (July 2014): 198–203. https://doi.org/10.1016/j.cct.2014.05.002.Full Text Link to Item
-
Kwak, Minjung, and Sin-Ho Jung. “Phase II clinical trials with time-to-event endpoints: optimal two-stage designs with one-sample log-rank test.” Stat Med 33, no. 12 (May 30, 2014): 2004–16. https://doi.org/10.1002/sim.6073.Full Text Link to Item
-
Rubenstein, James L., Bruce D. Cheson, Sin-Ho Jung, and Lawrence D. Kaplan. “Reply to M.C. Chamberlain.” J Clin Oncol 32, no. 8 (March 10, 2014): 858–59. https://doi.org/10.1200/JCO.2013.53.8942.Full Text Link to Item
-
Kim, Seok Jin, Insuk Sohn, In-Gu Do, Sin Ho Jung, Young Hyeh Ko, Hae Yong Yoo, Soonmyung Paik, and Won Seog Kim. “Gene expression profiles for the prediction of progression-free survival in diffuse large B cell lymphoma: results of a DASL assay.” Ann Hematol 93, no. 3 (March 2014): 437–47. https://doi.org/10.1007/s00277-013-1884-0.Full Text Link to Item
-
Hong, J. Y., M. E. Hong, M. K. Choi, Y. S. Kim, W. Chang, C. H. Maeng, S. Park, et al. “The impact of activated p-AKT expression on clinical outcomes in diffuse large B-cell lymphoma: a clinicopathological study of 262 cases.” Ann Oncol 25, no. 1 (January 2014): 182–88. https://doi.org/10.1093/annonc/mdt530.Full Text Link to Item
-
Jung, Sin-Ho, and Daniel J. Sargent. “Randomized phase II clinical trials.” J Biopharm Stat 24, no. 4 (2014): 802–16. https://doi.org/10.1080/10543406.2014.901343.Full Text Link to Item
-
Jung, Sin-Ho. “Stratified Fisher's exact test and its sample size calculation.” Biom J 56, no. 1 (January 2014): 129–40. https://doi.org/10.1002/bimj.201300048.Full Text Link to Item
-
Lee, Jeeyun, Insuk Sohn, In-Gu Do, Kyoung-Mee Kim, Se Hoon Park, Joon Oh Park, Young Suk Park, et al. “Nanostring-based multigene assay to predict recurrence for gastric cancer patients after surgery.” Plos One 9, no. 3 (2014): e90133. https://doi.org/10.1371/journal.pone.0090133.Full Text Link to Item
-
Lee, Yoo-Young, Tae-Joong Kim, Ji-Young Kim, Chel Hun Choi, In-Gu Do, Sang Yong Song, Insuk Sohn, et al. “Genetic profiling to predict recurrence of early cervical cancer.” Gynecol Oncol 131, no. 3 (December 2013): 650–54. https://doi.org/10.1016/j.ygyno.2013.10.003.Full Text Link to Item
-
Lee, Su Jin, Jongtae Lee, Jeeyun Lee, Se Hoon Park, Joon Oh Park, Young Suk Park, Ho Yeong Lim, et al. “Phase II trial of capecitabine and everolimus (RAD001) combination in refractory gastric cancer patients.” Invest New Drugs 31, no. 6 (December 2013): 1580–86. https://doi.org/10.1007/s10637-013-0022-0.Full Text Link to Item
-
Hou, Wei, Myron N. Chang, Sin-Ho Jung, and Yang Li. “Designs for randomized phase II clinical trials with two treatment arms.” Stat Med 32, no. 25 (November 10, 2013): 4367–79. https://doi.org/10.1002/sim.5829.Full Text Link to Item
-
Grant, Barbara W., Sin-Ho Jung, Jeffrey L. Johnson, Lale Kostakoglu, Eric Hsi, John C. Byrd, Jeffrey Jones, John P. Leonard, S Eric Martin, and Bruce D. Cheson. “A phase 2 trial of extended induction epratuzumab and rituximab for previously untreated follicular lymphoma: CALGB 50701.” Cancer 119, no. 21 (November 1, 2013): 3797–3804. https://doi.org/10.1002/cncr.28299.Full Text Link to Item
-
Lim, Ho-Yeong, Insuk Sohn, Shibing Deng, Jeeyun Lee, Sin Ho Jung, Mao Mao, Jiangchun Xu, et al. “Prediction of disease-free survival in hepatocellular carcinoma by gene expression profiling.” Ann Surg Oncol 20, no. 12 (November 2013): 3747–53. https://doi.org/10.1245/s10434-013-3070-y.Full Text Link to Item
-
Rubenstein, James L., Eric D. Hsi, Jeffrey L. Johnson, Sin-Ho Jung, Megan O. Nakashima, Barbara Grant, Bruce D. Cheson, and Lawrence D. Kaplan. “Intensive chemotherapy and immunotherapy in patients with newly diagnosed primary CNS lymphoma: CALGB 50202 (Alliance 50202).” J Clin Oncol 31, no. 25 (September 1, 2013): 3061–68. https://doi.org/10.1200/JCO.2012.46.9957.Full Text Link to Item
-
Amrhein, Timothy J., Matthew P. Lungren, Ben E. Paxton, Ramesh Srinivasan, Sin-Ho Jung, Miao Yu, James D. Eastwood, and Ramsey K. Kilani. “Journal Club: Shoulder MRI utilization: relationship of physician MRI equipment ownership to negative study frequency.” Ajr Am J Roentgenol 201, no. 3 (September 2013): 605–10. https://doi.org/10.2214/AJR.12.9977.Full Text Link to Item
-
Sun, J. -. M., Y. C. Ahn, E. K. Choi, M. -. J. Ahn, J. S. Ahn, S. -. H. Lee, D. H. Lee, et al. “Phase III trial of concurrent thoracic radiotherapy with either first- or third-cycle chemotherapy for limited-disease small-cell lung cancer.” Ann Oncol 24, no. 8 (August 2013): 2088–92. https://doi.org/10.1093/annonc/mdt140.Full Text Link to Item
-
Smith, Sonali M., Heiko Schöder, Jeffrey L. Johnson, Sin-Ho Jung, Nancy L. Bartlett, Bruce D. Cheson, and Bruce D. Alliance for Clinical Trials in Oncology. “The anti-CD80 primatized monoclonal antibody, galiximab, is well-tolerated but has limited activity in relapsed Hodgkin lymphoma: Cancer and Leukemia Group B 50602 (Alliance).” Leuk Lymphoma 54, no. 7 (July 2013): 1405–10. https://doi.org/10.3109/10428194.2012.744453.Full Text Link to Item
-
Park, S., I. R. Kim, K. K. Baek, S. J. Lee, W. J. Chang, C. H. Maeng, J. Y. Hong, et al. “Prospective analysis of quality of life in elderly patients treated with adjuvant chemotherapy for non-small-cell lung cancer.” Ann Oncol 24, no. 6 (June 2013): 1630–39. https://doi.org/10.1093/annonc/mds649.Full Text Link to Item
-
Pang, Herbert, and Sin-Ho Jung. “Sample size considerations of prediction-validation methods in high-dimensional data for survival outcomes.” Genet Epidemiol 37, no. 3 (April 2013): 276–82. https://doi.org/10.1002/gepi.21721.Full Text Link to Item
-
Kim, Jinseog, Insuk Sohn, Dae-Soon Son, Dong Hwan Kim, Taejin Ahn, and Sin-Ho Jung. “Prediction of a time-to-event trait using genome wide SNP data.” Bmc Bioinformatics 14 (February 19, 2013): 58. https://doi.org/10.1186/1471-2105-14-58.Full Text Link to Item
-
Choi, Jung-Hye, and Sin-Ho Jung. “Appropriate design of prospective studies.” J Clin Oncol 31, no. 4 (February 1, 2013): 510–11. https://doi.org/10.1200/JCO.2012.46.0980.Full Text Link to Item
-
Jung, S. -. H. “Stratified Fisher's exact test and its sample size calculation.” Biometrical Journal, 2013.
-
Kim, Jinseog, Insuk Sohn, Dennis Dong Hwan Kim, and Sin-Ho Jung. “SNP selection in genome-wide association studies via penalized support vector machine with MAX test.” Comput Math Methods Med 2013 (2013): 340678. https://doi.org/10.1155/2013/340678.Full Text Link to Item
-
Kwak, M., and S. -. H. Jung. “Phase II clinical trials with time-to-event endpoints: Optimal two-stage designs with one-sample log-rank test.” Statistics in Medicine, 2013.
-
Lee, Y. -. Y., T. -. J. Kim, J. -. Y. Kim, C. H. Choi, I. -. G. Do, S. Y. Song, I. Sohn, et al. “Genetic profiling to predict recurrence of early cervical cancer.” Gynecologic Oncology, 2013.
-
Kostakoglu, Lale, Heiko Schöder, Jeffrey L. Johnson, Nathan C. Hall, Lawrence H. Schwartz, David J. Straus, Ann S. LaCasce, et al. “Interim [(18)F]fluorodeoxyglucose positron emission tomography imaging in stage I-II non-bulky Hodgkin lymphoma: would using combined positron emission tomography and computed tomography criteria better predict response than each test alone?” Leuk Lymphoma 53, no. 11 (November 2012): 2143–50. https://doi.org/10.3109/10428194.2012.676173.Full Text Link to Item
-
Czuczman, M. S., J. P. Leonard, S. Jung, J. L. Johnson, E. D. Hsi, J. C. Byrd, and B. D. Cheson. “Phase II trial of galiximab (anti-CD80 monoclonal antibody) plus rituximab (CALGB 50402): Follicular Lymphoma International Prognostic Index (FLIPI) score is predictive of upfront immunotherapy responsiveness.” Ann Oncol 23, no. 9 (September 2012): 2356–62. https://doi.org/10.1093/annonc/mdr620.Full Text Link to Item
-
Lugogo, Njira L., John W. Hollingsworth, Druhan L. Howell, Loretta G. Que, Dave Francisco, Tony D. Church, Erin N. Potts-Kant, et al. “Alveolar macrophages from overweight/obese subjects with asthma demonstrate a proinflammatory phenotype.” Am J Respir Crit Care Med 186, no. 5 (September 1, 2012): 404–11. https://doi.org/10.1164/rccm.201109-1671OC.Full Text Link to Item
-
Owzar, Kouros, Zhiguo Li, Nancy Cox, and Sin-Ho Jung. “Power and sample size calculations for SNP association studies with censored time-to-event outcomes.” Genet Epidemiol 36, no. 6 (September 2012): 538–48. https://doi.org/10.1002/gepi.21645.Full Text Link to Item
-
Kim, J., I. Sohn, S. H. Jung, S. Kim, and C. Park. “Analysis of survival data with group lasso.” Communications in Statistics: Simulation and Computation 41, no. 9 (July 2, 2012): 1593–1605. https://doi.org/10.1080/03610918.2011.611311.Full Text
-
Lim, J., W. Lee, S. H. Jung, K. E. Lee, and S. C. Yun. “A regression model for the AUC of clustered ordinal test results and working independent optimal weights.” Communications in Statistics: Simulation and Computation 41, no. 8 (July 2, 2012): 1397–1410. https://doi.org/10.1080/03610918.2011.600501.Full Text
-
Paxton, Ben E., Matthew P. Lungren, Ramesh C. Srinivasan, Sin-Ho Jung, Miao Yu, James D. Eastwood, and Ramsey K. Kilani. “Physician self-referral of lumbar spine MRI with comparative analysis of negative study rates as a marker of utilization appropriateness.” Ajr Am J Roentgenol 198, no. 6 (June 2012): 1375–79. https://doi.org/10.2214/AJR.11.7730.Full Text Link to Item
-
Wilson, Wyndham H., Sin-Ho Jung, Pierluigi Porcu, David Hurd, Jeffrey Johnson, S Eric Martin, Myron Czuczman, et al. “A Cancer and Leukemia Group B multi-center study of DA-EPOCH-rituximab in untreated diffuse large B-cell lymphoma with analysis of outcome by molecular subtype.” Haematologica 97, no. 5 (May 2012): 758–65. https://doi.org/10.3324/haematol.2011.056531.Full Text Link to Item
-
Lee, Jeeyun, Do Hoon Lim, Sung Kim, Se Hoon Park, Joon Oh Park, Young Suk Park, Ho Yeong Lim, et al. “Phase III trial comparing capecitabine plus cisplatin versus capecitabine plus cisplatin with concurrent capecitabine radiotherapy in completely resected gastric cancer with D2 lymph node dissection: the ARTIST trial.” J Clin Oncol 30, no. 3 (January 20, 2012): 268–73. https://doi.org/10.1200/JCO.2011.39.1953.Full Text Link to Item
-
Jung, Sin-Ho, Myron N. Chang, and Sun J. Kang. “Phase II cancer clinical trials with heterogeneous patient populations.” J Biopharm Stat 22, no. 2 (2012): 312–28. https://doi.org/10.1080/10543406.2010.536873.Full Text Link to Item
-
Jung, Sin-Ho, and S Stanley Young. “Power and sample size calculation for microarray studies.” J Biopharm Stat 22, no. 1 (2012): 30–42. https://doi.org/10.1080/10543406.2010.500066.Full Text Link to Item
-
Jung, Sin-Ho, and Shein-Chung Chow. “On sample size calculation for comparing survival curves under general hypothesis testing.” J Biopharm Stat 22, no. 3 (2012): 485–95. https://doi.org/10.1080/10543406.2010.550701.Full Text Link to Item
-
Kim, Seung Tae, Ji Eun Uhm, Jeeyun Lee, Jong-mu Sun, Insuk Sohn, Seon Woo Kim, Sin-Ho Jung, et al. “Randomized phase II study of gefitinib versus erlotinib in patients with advanced non-small cell lung cancer who failed previous chemotherapy.” Lung Cancer 75, no. 1 (January 2012): 82–88. https://doi.org/10.1016/j.lungcan.2011.05.022.Full Text Link to Item
-
Wood, M. E., F. Kingsley, A. B. Ambaye, L. Yee, S. -. H. Jung, J. R. Marshall, and E. Paskett. “A Randomized Phase II Trial of Vitamin D vs Placebo in Premenopausal Women: CALGB 70806.” Cancer Research 71 (December 15, 2011). https://doi.org/10.1158/0008-5472.SABCS11-01-2-04-01.Full Text Link to Item
-
Owzar, Kouros, William T. Barry, and Sin-Ho Jung. “Statistical considerations for analysis of microarray experiments.” Clin Transl Sci 4, no. 6 (December 2011): 466–77. https://doi.org/10.1111/j.1752-8062.2011.00309.x.Full Text Link to Item
-
Shin, J. H., S. L. Jung, J. H. Baek, and J. -. H. Kim. “Rupture of benign thyroid tumors after radio-frequency ablation.” Ajnr Am J Neuroradiol 32, no. 11 (December 2011): 2165–69. https://doi.org/10.3174/ajnr.A2661.Full Text Link to Item
-
Stedman, Margaret R., David R. Gagnon, Robert A. Lew, Sin-Ho Jung, Elena Losina, and M Alan Brookhart. “A SAS macro for a clustered logrank test.” Comput Methods Programs Biomed 104, no. 2 (November 2011): 266–70. https://doi.org/10.1016/j.cmpb.2011.02.001.Full Text Link to Item
-
Chang, M., S. H. Jung, and S. S. Wu. “Two-stage designs with additional futility tests for phase ii clinical trials with heterogeneous patient populations.” Sequential Analysis 30, no. 3 (July 1, 2011): 338–49. https://doi.org/10.1080/07474946.2011.593924.Full Text
-
Sohn, Insuk, Kouros Owzar, Johan Lim, Stephen L. George, Stephanie Mackey Cushman, and Sin-Ho Jung. “Multiple testing for gene sets from microarray experiments.” Bmc Bioinformatics 12 (May 26, 2011): 209. https://doi.org/10.1186/1471-2105-12-209.Full Text Open Access Copy Link to Item
-
Morrison, V. A., S. Jung, J. L. Johnson, J. Leonard, B. D. Cheson, and B. D. Cancer and Leukemia Group B. “A phase II trial of bortezomib plus lenalidomide for relapsed/refractory mantle cell lymphoma (MCL) (CALGB 50501).” J Clin Oncol 29, no. 15_suppl (May 20, 2011): TPS223.Link to Item
-
Morrison, V. A., S. Jung, J. L. Johnson, J. Leonard, and B. D. Cheson. “A phase II trial of bortezomib plus lenalidomide for relapsed/refractory mantle cell lymphoma (MCL) (CALGB 50501).” Journal of Clinical Oncology 29, no. 15_suppl (May 20, 2011): TPS223–TPS223. https://doi.org/10.1200/jco.2011.29.15_suppl.tps223.Full Text
-
Straus, David J., Jeffrey L. Johnson, Ann S. LaCasce, Nancy L. Bartlett, Lale Kostakoglu, Eric D. Hsi, Heiko Schöder, et al. “Doxorubicin, vinblastine, and gemcitabine (CALGB 50203) for stage I/II nonbulky Hodgkin lymphoma: pretreatment prognostic factors and interim PET.” Blood 117, no. 20 (May 19, 2011): 5314–20. https://doi.org/10.1182/blood-2010-10-314260.Full Text Link to Item
-
Furman, Richard R., Michael L. Grossbard, Jeffrey L. Johnson, Andrew L. Pecora, Peter A. Cassileth, Sin-Ho Jung, Bruce A. Peterson, et al. “A phase III study of anti-B4-blocked ricin as adjuvant therapy post-autologous bone marrow transplant: CALGB 9254.” Leuk Lymphoma 52, no. 4 (April 2011): 587–96. https://doi.org/10.3109/10428194.2010.543714.Full Text Link to Item
-
Choi, So-Jung, Sung-Hyun Kim, Ho Y. Kang, Jinseon Lee, Jong H. Bhak, Insuk Sohn, Sin-Ho Jung, et al. “Mutational hotspots in the mitochondrial genome of lung cancer.” Biochem Biophys Res Commun 407, no. 1 (April 1, 2011): 23–27. https://doi.org/10.1016/j.bbrc.2011.02.078.Full Text Link to Item
-
Blum, K. A., S. -. H. Jung, J. L. Johnson, T. S. Lin, E. D. Hsi, D. M. Lucas, J. C. Byrd, B. D. Cheson, N. L. Bartlett, and N. L. Cancer and Leukemia Group B. “Serious pulmonary toxicity in patients with Hodgkin's lymphoma with SGN-30, gemcitabine, vinorelbine, and liposomal doxorubicin is associated with an FcγRIIIa-158 V/F polymorphism.” Ann Oncol 21, no. 11 (November 2010): 2246–54. https://doi.org/10.1093/annonc/mdq211.Full Text Link to Item
-
Sohn, Insuk, Kouros Owzar, Stephen L. George, Sujong Kim, and Sin-Ho Jung. “Robust test method for time-course microarray experiments.” Bmc Bioinformatics 11 (July 22, 2010): 391. https://doi.org/10.1186/1471-2105-11-391.Full Text Open Access Copy Link to Item
-
Augustine, Christina K., Hiroaki Toshimitsu, Sin-Ho Jung, Patricia A. Zipfel, Jin S. Yoo, Yasunori Yoshimoto, M Angelica Selim, et al. “Sorafenib, a multikinase inhibitor, enhances the response of melanoma to regional chemotherapy.” Mol Cancer Ther 9, no. 7 (July 2010): 2090–2101. https://doi.org/10.1158/1535-7163.MCT-10-0073.Full Text Link to Item
-
Shterev, Ivo D., Sin-Ho Jung, Stephen L. George, and Kouros Owzar. “permGPU: Using graphics processing units in RNA microarray association studies.” Bmc Bioinformatics 11 (June 16, 2010): 329. https://doi.org/10.1186/1471-2105-11-329.Full Text Open Access Copy Link to Item
-
Kaplan, L. D., S. Jung, J. L. Johnson, C. A. Linker, J. C. Byrd, W. Stock, E. D. Hsi, and B. D. Cheson. “A randomized phase II trial of maintenance versus consolidation bortezomib therapy following aggressive chemo-immunotherapy and autologous stem cell transplant for previously untreated mantle cell lymphoma.” Journal of Clinical Oncology 28, no. 15_suppl (May 20, 2010): TPS306–TPS306. https://doi.org/10.1200/jco.2010.28.15_suppl.tps306.Full Text
-
Morrison, V. A., J. L. Johnson, S. Jung, J. P. Leonard, and B. D. Cheson. “A phase II trial of bortezomib plus lenalidomide for relapsed/refractory mantle cell lymphoma (MCL) (CALGB 50501): Results of a planned interim analysis.” Journal of Clinical Oncology 28, no. 15_suppl (May 20, 2010): 8106–8106. https://doi.org/10.1200/jco.2010.28.15_suppl.8106.Full Text
-
Smith, S. M., N. Bartlett, J. L. Johnson, J. Lister, A. F. Cashen, S. Jung, H. Schöder, K. Egan, and B. D. Cheson. “Galiximab, an anti-CD80 primatized monoclonal antibody, in relapsed Hodgkin lymphoma: Final results of CALGB 50602.” Journal of Clinical Oncology 28, no. 15_suppl (May 20, 2010): 8039–8039. https://doi.org/10.1200/jco.2010.28.15_suppl.8039.Full Text
-
Kim, W. S., S. J. Kim, and S. H. Jung. “Reply to K. Shimada et al.” Journal of Clinical Oncology 28, no. 14 (May 10, 2010). https://doi.org/10.1200/JCO.2010.28.0289.Full Text
-
Augustine, Christina K., Sin-Ho Jung, Insuk Sohn, Jin Soo Yoo, Yasunori Yoshimoto, John A. Olson, Henry S. Friedman, Francis Ali-Osman, and Douglas S. Tyler. “Gene expression signatures as a guide to treatment strategies for in-transit metastatic melanoma.” Mol Cancer Ther 9, no. 4 (April 2010): 779–90. https://doi.org/10.1158/1535-7163.MCT-09-0764.Full Text Link to Item
-
Jung, Sin-Ho. “Sample size and power calculation for molecular biology studies.” Methods Mol Biol 620 (2010): 203–18. https://doi.org/10.1007/978-1-60761-580-4_5.Full Text Link to Item
-
Jung, Sin-Ho, Jong-Hyeon Jeong, and Hanna Bandos. “Regression on quantile residual life.” Biometrics 65, no. 4 (December 2009): 1203–12. https://doi.org/10.1111/j.1541-0420.2009.01196.x.Full Text Link to Item
-
Sohn, Insuk, Kouros Owzar, Stephen L. George, Sujong Kim, and Sin-Ho Jung. “A permutation-based multiple testing method for time-course microarray experiments.” Bmc Bioinformatics 10 (October 15, 2009): 336. https://doi.org/10.1186/1471-2105-10-336.Full Text Link to Item
-
Sohn, Insuk, Jinseog Kim, Sin-Ho Jung, and Changyi Park. “Gradient lasso for Cox proportional hazards model.” Bioinformatics 25, no. 14 (July 15, 2009): 1775–81. https://doi.org/10.1093/bioinformatics/btp322.Full Text Link to Item
-
Jung, Sin-Ho, Insuk Sohn, Stephen L. George, Liping Feng, and Phyllis C. Leppert. “Sample size calculation for microarray experiments with blocked one-way design.” Bmc Bioinformatics 10 (May 28, 2009): 164. https://doi.org/10.1186/1471-2105-10-164.Full Text Link to Item
-
Schuman, Stefanie G., Anjum F. Koreishi, Sina Farsiu, Sin-ho Jung, Joseph A. Izatt, and Cynthia A. Toth. “Photoreceptor layer thinning over drusen in eyes with age-related macular degeneration imaged in vivo with spectral-domain optical coherence tomography.” Ophthalmology 116, no. 3 (March 2009): 488-496.e2. https://doi.org/10.1016/j.ophtha.2008.10.006.Full Text Link to Item
-
Jung, Sin-Ho, and Stephen L. George. “Between-arm comparisons in randomized Phase II trials.” J Biopharm Stat 19, no. 3 (2009): 456–68. https://doi.org/10.1080/10543400902802391.Full Text Link to Item
-
Hyslop, Terry, and Sin-Ho Jung. “Journal of Biopharmaceutical Statistics. From the editors.” J Biopharm Stat 19, no. 3 (2009): 413. https://doi.org/10.1080/10543400902800452.Full Text Link to Item
-
Owzar, K., and S. H. Jung. “Authors' response.” Clinical Trials 5, no. 3 (December 1, 2008): 223–24. https://doi.org/10.1177/17407745080050031102.Full Text
-
Hsi, Eric D., Sin-Ho Jung, Raymond Lai, Jeffrey L. Johnson, James R. Cook, Dan Jones, Sven Devos, Bruce D. Cheson, Lloyd E. Damon, and Jonathan Said. “Ki67 and PIM1 expression predict outcome in mantle cell lymphoma treated with high dose therapy, stem cell transplantation and rituximab: a Cancer and Leukemia Group B 59909 correlative science study.” Leuk Lymphoma 49, no. 11 (November 2008): 2081–90. https://doi.org/10.1080/10428190802419640.Full Text Link to Item
-
Owzar, Kouros, William T. Barry, Sin-Ho Jung, Insuk Sohn, and Stephen L. George. “Statistical challenges in preprocessing in microarray experiments in cancer.” Clin Cancer Res 14, no. 19 (October 1, 2008): 5959–66. https://doi.org/10.1158/1078-0432.CCR-07-4532.Full Text Link to Item
-
Lim, Johan, Xinlei Wang, Seokho Lee, and Sin-Ho Jung. “A distribution-free test of constant mean in linear mixed effects models.” Stat Med 27, no. 19 (August 30, 2008): 3833–46. https://doi.org/10.1002/sim.3275.Full Text Link to Item
-
Jung, Sin-Ho. “Sample size calculation for the weighted rank statistics with paired survival data.” Stat Med 27, no. 17 (July 30, 2008): 3350–65. https://doi.org/10.1002/sim.3189.Full Text Link to Item
-
Lai, Raymond, Nancy L. Bartlett, John R. Mackey, Sin-Ho Jung, Jeffrey L. Johnson, James R. Cook, Dan Jones, et al. “High expression of nucleoside transporter protein hENT1 in Reed-Sternberg cells is associated with treatment failure in relapsed/refractory Hodgkin lymphoma patients treated with gemcitabine, vinorelbine and liposomal doxorubicin - a CALGB 59804 correlative study.” Leuk Lymphoma 49, no. 6 (June 2008): 1202–5. https://doi.org/10.1080/10428190802094237.Full Text Link to Item
-
Augustine, C. K., S. Jung, A. Potti, I. Sohn, J. S. Yoo, P. Zipfel, J. Olson, F. Ali-Osman, J. R. Nevins, and D. S. Tyler. “Gene expression signatures as a guide to treatment strategies for in-transit metastatic melanoma.” J Clin Oncol 26, no. 15_suppl (May 20, 2008): 9077.Link to Item
-
Hsi, E., S. Jung, R. Lai, J. Johnson, J. Cook, D. Jones, S. DeVos, B. D. Cheson, L. E. Damon, and J. Said. “Ki67 and PIM1 expression in aggressively treated mantle cell lymphoma (MCL): A Cancer and Leukemia Group B (CALGB) 59909 correlative science study.” J Clin Oncol 26, no. 15_suppl (May 20, 2008): 8560.Link to Item
-
Augustine, C. K., S. Jung, A. Potti, I. Sohn, J. S. Yoo, P. Zipfel, J. Olson, F. Ali-Osman, J. R. Nevins, and D. S. Tyler. “Gene expression signatures as a guide to treatment strategies for in-transit metastatic melanoma.” Journal of Clinical Oncology 26, no. 15_suppl (May 20, 2008): 9077–9077. https://doi.org/10.1200/jco.2008.26.15_suppl.9077.Full Text
-
Hsi, E., S. Jung, R. Lai, J. Johnson, J. Cook, D. Jones, S. DeVos, B. D. Cheson, L. E. Damon, and J. Said. “Ki67 and PIM1 expression in aggressively treated mantle cell lymphoma (MCL): A Cancer and Leukemia Group B (CALGB) 59909 correlative science study.” Journal of Clinical Oncology 26, no. 15_suppl (May 20, 2008): 8560–8560. https://doi.org/10.1200/jco.2008.26.15_suppl.8560.Full Text
-
Erdmann, Detlev, Keith E. Follmar, Marlieke Debruijn, Anthony D. Bruno, Sin-Ho Jung, David Edelman, Srinivasan Mukundan, and Jeffrey R. Marcus. “A retrospective analysis of facial fracture etiologies.” Ann Plast Surg 60, no. 4 (April 2008): 398–403. https://doi.org/10.1097/SAP.0b013e318133a87b.Full Text Link to Item
-
Jeong, Jong-Hyeon, Sin-Ho Jung, and Joseph P. Costantino. “Nonparametric inference on median residual life function.” Biometrics 64, no. 1 (March 2008): 157–63. https://doi.org/10.1111/j.1541-0420.2007.00826.x.Full Text Link to Item
-
Jung, S. H., C. Kim, and S. C. Chow. “Sample size calculation for the log-rank tests for multi-arm trials with a control.” Journal of the Korean Statistical Society 37, no. 1 (March 1, 2008): 11–22. https://doi.org/10.1016/j.jkss.2007.11.001.Full Text
-
Jung, Sin-Ho. “Randomized phase II trials with a prospective control.” Stat Med 27, no. 4 (February 20, 2008): 568–83. https://doi.org/10.1002/sim.2961.Full Text Link to Item
-
Jung, S. H. “Sample size calculation for paired survival data: A simulation method.” Journal of Statistical Computation and Simulation 78, no. 1 (January 28, 2008): 85–92. https://doi.org/10.1080/10629360600864951.Full Text
-
Behera, M. A., L. Feng, B. Yonish, W. Catherino, S. H. Jung, and P. Leppert. “Thrombospondin-1 and thrombospondin-2 mRNA and TSP-1 and TSP-2 protein expression in uterine fibroids and correlation to the genes COL1A1 and COL3A1 and to the collagen cross-link hydroxyproline (Reproductive Sciences (2007) 14, 8, (63S-76S) DOI: 10.1177/1933719107309591).” Reproductive Sciences 15, no. 1 (January 1, 2008): 97. https://doi.org/10.1177/1933719108314501.Full Text
-
Jung, Sin-Ho, Huiman X. Barnhart, Insuk Sohn, Sandra S. Stinnett, and David K. Wallace. “Sample size for comparing correlated concordance rates.” J Biopharm Stat 18, no. 2 (2008): 359–69. https://doi.org/10.1080/10543400701697216.Full Text Link to Item
-
Owzar, Kouros, and Sin-Ho Jung. “Designing phase II studies in cancer with time-to-event endpoints.” Clin Trials 5, no. 3 (2008): 209–21. https://doi.org/10.1177/1740774508091748.Full Text Link to Item
-
Owzar, Kouros, Sin-Ho Jung, and Pranab Kumar Sen. “A copula approach for detecting prognostic genes associated with survival outcome in microarray studies.” Biometrics 63, no. 4 (December 2007): 1089–98. https://doi.org/10.1111/j.1541-0420.2007.00802.x.Full Text Link to Item
-
Behera, Millie A., Liping Feng, Bryan Yonish, William Catherino, Sin-Ho Jung, and Phyllis Leppert. “Thrombospondin-1 and thrombospondin-2 mRNA and TSP-1 and TSP-2 protein expression in uterine fibroids and correlation to the genes COL1A1 and COL3A1 and to the collagen cross-link hydroxyproline.” Reprod Sci 14, no. 8 Suppl (December 2007): 63–76. https://doi.org/10.1177/1933719107309591.Full Text Link to Item
-
Zhao, Chen, Jordan Blum, Alan Chen, Hyog Young Kwon, Seung Hye Jung, J Michael Cook, Anand Lagoo, and Tannishtha Reya. “Loss of beta-catenin impairs the renewal of normal and CML stem cells in vivo.” Cancer Cell 12, no. 6 (December 2007): 528–41. https://doi.org/10.1016/j.ccr.2007.11.003.Full Text Link to Item
-
Wallace, David K., Sharon F. Freedman, Zheen Zhao, and Sin-Ho Jung. “Accuracy of ROPtool vs individual examiners in assessing retinal vascular tortuosity.” Arch Ophthalmol 125, no. 11 (November 2007): 1523–30. https://doi.org/10.1001/archopht.125.11.1523.Full Text Link to Item
-
Lee, Jaeyong, Jinseog Kim, and Sin-Ho Jung. “Bayesian analysis of paired survival data using a bivariate exponential distribution.” Lifetime Data Anal 13, no. 1 (March 2007): 119–37. https://doi.org/10.1007/s10985-006-9022-0.Full Text Link to Item
-
Jung, Sin-Ho, Shein-Chung Chow, and Eric M. Chi. “A note on sample size calculation based on propensity analysis in nonrandomized trials.” J Biopharm Stat 17, no. 1 (2007): 35–41. https://doi.org/10.1080/10543400601044790.Full Text Link to Item
-
Jung, Sin-Ho. “Sample size calculation for weighted rank tests comparing survival distributions under cluster randomization: a simulation method.” J Biopharm Stat 17, no. 5 (2007): 839–49. https://doi.org/10.1080/10543400701513983.Full Text Link to Item
-
Jung, S. H., K. Owzar, S. L. George, and T. Lee. “Rejoinder.” Journal of Biopharmaceutical Statistics 16, no. 6 (December 1, 2006): 781–83. https://doi.org/10.1080/10543400600954452.Full Text
-
Jung, Sin-Ho, and Woncheol Jang. “How accurately can we control the FDR in analyzing microarray data?” Bioinformatics 22, no. 14 (July 15, 2006): 1730–36. https://doi.org/10.1093/bioinformatics/btl161.Full Text Link to Item
-
Lai, R., E. D. Hsi, J. Mackey, S. Jung, J. L. Johnson, J. R. Cook, D. Jones, J. W. Said, B. D. Cheson, and N. L. Bartlett. “High expression of nucleoside transporter hENT1 predicts a worse event-free survival in relapsed/refractory Hodgkin lymphoma patients treated with gemcitabine, vinorelbine, and liposomal doxorubicin-A CALGB 59804 correlative study.” J Clin Oncol 24, no. 18_suppl (June 20, 2006): 7581.Link to Item
-
Jeong, Jong-Hyeon, and Sin-Ho Jung. “Rank tests for clustered survival data when dependent subunits are randomized.” Stat Med 25, no. 3 (February 15, 2006): 361–73. https://doi.org/10.1002/sim.2218.Full Text Link to Item
-
Jung, Sin-Ho, Kouros Owzar, Stephen L. George, and Taiyeong Lee. “P-value calculation for multistage phase II cancer clinical trials.” J Biopharm Stat 16, no. 6 (2006): 765–75. https://doi.org/10.1080/10543400600825645.Full Text Link to Item
-
Jung, Sin-Ho, Kouros Owzar, and Stephen L. George. “A multiple testing procedure to associate gene expression levels with survival.” Stat Med 24, no. 20 (October 30, 2005): 3077–88. https://doi.org/10.1002/sim.2179.Full Text Link to Item
-
Jung, Sin-Ho, and Chul W. Ahn. “Sample size for a two-group comparison of repeated binary measurements using GEE.” Stat Med 24, no. 17 (September 15, 2005): 2583–96. https://doi.org/10.1002/sim.2136.Full Text Link to Item
-
Jung, Sin-Ho. “Sample size for FDR-control in microarray data analysis.” Bioinformatics 21, no. 14 (July 15, 2005): 3097–3104. https://doi.org/10.1093/bioinformatics/bti456.Full Text Link to Item
-
Ganjoo, Kristen N., Michael J. Robertson, William Fisher, Sin-Ho Jung, John McClean, Sang Yoon Huh, Jose Bufill, Sheron Williams, and Larry D. Cripe. “A phase II study of single agent gemcitabine in relapsed or refractory follicular or small lymphocytic non-Hodgkin lymphomas: a Hoosier Oncology Group Study.” Am J Clin Oncol 28, no. 2 (April 2005): 169–72. https://doi.org/10.1097/01.coc.0000144812.74663.d0.Full Text Link to Item
-
Ahn, Chul, and Sin-Ho Jung. “Effect of dropouts on sample size estimates for test on trends across repeated measurements.” J Biopharm Stat 15, no. 1 (2005): 33–41. https://doi.org/10.1081/bip-200040809.Full Text Link to Item
-
Bang, Heejung, Sin-Ho Jung, and Stephen L. George. “Sample size calculation for simulation-based multiple-testing procedures.” J Biopharm Stat 15, no. 6 (2005): 957–67. https://doi.org/10.1080/10543400500265710.Full Text Link to Item
-
Jung, Sin-Ho, Heejung Bang, and Stanley Young. “Sample size calculation for multiple testing in microarray data analysis.” Biostatistics 6, no. 1 (January 2005): 157–69. https://doi.org/10.1093/biostatistics/kxh026.Full Text Link to Item
-
Jung, Sin-Ho, Sun J. Kang, Linda M. McCall, and Brent Blumenstein. “Sample size computation for two-sample noninferiority log-rank test.” J Biopharm Stat 15, no. 6 (2005): 969–79. https://doi.org/10.1080/10543400500265736.Full Text Link to Item
-
Jung, Sin-Ho, and Kyung Mann Kim. “On the estimation of the binomial probability in multistage clinical trials.” Stat Med 23, no. 6 (March 30, 2004): 881–96. https://doi.org/10.1002/sim.1653.Full Text Link to Item
-
Jung, Sin-Ho, Taiyeong Lee, KyungMann Kim, and Stephen L. George. “Admissible two-stage designs for phase II cancer clinical trials.” Stat Med 23, no. 4 (February 28, 2004): 561–69. https://doi.org/10.1002/sim.1600.Full Text Link to Item
-
Henegariu, Octavian, Nyla A. Heerema, Virginia Thurston, Sin-Ho Jung, Martin Pera, and Gail H. Vance. “Characterization of gains, losses, and regional amplification in testicular germ cell tumor cell lines by comparative genomic hybridization.” Cancer Genet Cytogenet 148, no. 1 (January 1, 2004): 14–20. https://doi.org/10.1016/s0165-4608(03)00211-5.Full Text Link to Item
-
Ahn, C., S. H. Jung, and S. H. Kang. “Weighted random regression models and dropouts.” Drug Information Journal 38, no. 2 (2004): 135–41.
-
Ahn, C., and S. H. Jung. “Efficiency of the slope estimator in repeated measurements.” Drug Information Journal 38, no. 2 (2004): 143–48.
-
Jung, S. H., and C. Ahn. “K-sample test and sample size calculation for comparing slopes in data with repeated measurements.” Biometrical Journal 46, no. 5 (January 1, 2004): 554–64. https://doi.org/10.1002/bimj.200310050.Full Text
-
Passik, Steven D., Rudolph M. Navari, Sin-Ho Jung, Cindy Nagy, Jake Vinson, Kenneth L. Kirsh, and Patrick Loehrer. “A phase I trial of olanzapine (Zyprexa) for the prevention of delayed emesis in cancer patients: a Hoosier Oncology Group study.” Cancer Invest 22, no. 3 (2004): 383–88. https://doi.org/10.1081/cnv-200029066.Full Text Link to Item
-
Reed, Carolyn E., David H. Harpole, Katherine E. Posther, Sandra L. Woolson, Robert J. Downey, Bryan F. Meyers, Robert T. Heelan, et al. “Results of the American College of Surgeons Oncology Group Z0050 trial: the utility of positron emission tomography in staging potentially operable non-small cell lung cancer.” J Thorac Cardiovasc Surg 126, no. 6 (December 2003): 1943–51. https://doi.org/10.1016/j.jtcvs.2003.07.030.Full Text Link to Item
-
Kang, S. H., C. W. Ahn, and S. H. Jung. “Sample Size Calculation for Dichotomous Outcomes in Cluster Randomization Trials with Varying Cluster Size.” Drug Information Journal 37, no. 1 (November 3, 2003): 109–14.
-
Jung, S. H., and Z. Ying. “Rank-based regression with repeated measurements data.” Biometrika 90, no. 3 (September 1, 2003): 732–40. https://doi.org/10.1093/biomet/90.3.732.Full Text
-
Wagner, Jeffrey D., Jaimie Ranieri, David Z. Evdokimow, Theodore Logan, Tsu-Yi Chuang, Cynthia S. Johnson, Sin-Ho Jung, Stacie Wenck, and John J. Coleman. “Patterns of initial recurrence and prognosis after sentinel lymph node biopsy and selective lymphadenectomy for melanoma.” Plast Reconstr Surg 112, no. 2 (August 2003): 486–97. https://doi.org/10.1097/01.PRS.0000070989.23469.1F.Full Text Link to Item
-
Fisch, Michael J., Michael L. Titzer, Jean L. Kristeller, Jianzhao Shen, Patrick J. Loehrer, Sin-Ho Jung, Steven D. Passik, and Lawrence H. Einhorn. “Assessment of quality of life in outpatients with advanced cancer: the accuracy of clinician estimations and the relevance of spiritual well-being--a Hoosier Oncology Group Study.” J Clin Oncol 21, no. 14 (July 15, 2003): 2754–59. https://doi.org/10.1200/JCO.2003.06.093.Full Text Link to Item
-
Fisch, Michael J., Patrick J. Loehrer, Jean Kristeller, Steven Passik, Sin-Ho Jung, Jianzhao Shen, Matthew A. Arquette, Mary J. Brames, Lawrence H. Einhorn, and Lawrence H. Hoosier Oncology Group. “Fluoxetine versus placebo in advanced cancer outpatients: a double-blinded trial of the Hoosier Oncology Group.” J Clin Oncol 21, no. 10 (May 15, 2003): 1937–43. https://doi.org/10.1200/JCO.2003.08.025.Full Text Link to Item
-
Jung, Sin-Ho, Seung-Ho Kang, and Chul Ahn. “Chi-square test for R x C contingency tables with clustered data.” J Biopharm Stat 13, no. 2 (May 2003): 241–51. https://doi.org/10.1081/BIP-120019269.Full Text Link to Item
-
Jung, Sin-Ho, and Chul Ahn. “Sample size estimation for GEE method for comparing slopes in repeated measurements data.” Stat Med 22, no. 8 (April 30, 2003): 1305–15. https://doi.org/10.1002/sim.1384.Full Text Link to Item
-
Jung, Sin-Ho, and Jong-Hyeon Jeong. “Rank tests for clustered survival data.” Lifetime Data Anal 9, no. 1 (March 2003): 21–33. https://doi.org/10.1023/a:1021869803601.Full Text Link to Item
-
Schauwecker, D. S., A. R. Siddiqui, J. D. Wagner, D. Davidson, S. -. H. Jung, K. A. Carlson, and G. D. Hutchins. “Melanoma patients evaluated by four different positron emission tomography reconstruction techniques.” Nucl Med Commun 24, no. 3 (March 2003): 281–89. https://doi.org/10.1097/00006231-200303000-00008.Full Text Link to Item
-
Schauwecker, D. S., A. R. Siddiqui, J. D. Wagner, D. Davidson, S. H. Jung, K. A. Carlson, and G. D. Hutchins. “Melanoma patients evaluated by four different positron emission tomography reconstruction techniques.” Nuclear Medicine Communications 24, no. 3 (March 1, 2003): 281–89.
-
Jeong, Jong-Hyeon, Sin-Ho Jung, and Samuel Wieand. “A parametric model for long-term follow-up data from phase III breast cancer clinical trials.” Stat Med 22, no. 3 (February 15, 2003): 339–52. https://doi.org/10.1002/sim.1349.Full Text Link to Item
-
Ahn, C., and S. H. Jung. “Efficiency of General Estimating Equations Estimators of Slopes in Repeated Measurements: Adding Subjects or Adding Measurements?” Therapeutic Innovation &Amp; Regulatory Science 37, no. 3 (January 1, 2003): 309–16. https://doi.org/10.1177/009286150303700306.Full Text
-
George, David W., Richard S. Foster, Robert A. Hromas, Kent A. Robertson, Gail H. Vance, Thomas M. Ulbright, Troy A. Gobbett, et al. “Update on late relapse of germ cell tumor: a clinical and molecular analysis.” J Clin Oncol 21, no. 1 (January 1, 2003): 113–22. https://doi.org/10.1200/JCO.2003.03.019.Full Text Link to Item
-
Kong, S. H., C. W. Ahn, and S. H. Jung. “Sample Size Calculation for Dichotomous Outcomes in Cluster Randomization Trials with Varying Cluster Size.” Therapeutic Innovation &Amp; Regulatory Science 37, no. 1 (January 1, 2003): 109–14. https://doi.org/10.1177/009286150303700113.Full Text
-
Ahn, C., S. H. Jung, and S. H. Kang. “An Evaluation of Weighted Chi-Square Statistics for Clustered Binary Data.” Drug Information Journal 37, no. 1 (2003): 91–99.
-
Jung, Sin-Ho, and Siu Hui. “Sample size calculation for rank tests comparing K survival distributions.” Lifetime Data Anal 8, no. 4 (December 2002): 361–73. https://doi.org/10.1023/a:1020518905233.Full Text Link to Item
-
Cripe, L. D., V. M. Gelfanov, E. A. Smith, D. R. Spigel, C. A. Phillips, T. G. Gabig, S. -. H. Jung, et al. “Role for c-jun N-terminal kinase in treatment-refractory acute myeloid leukemia (AML): signaling to multidrug-efflux and hyperproliferation.” Leukemia 16, no. 5 (May 2002): 799–812. https://doi.org/10.1038/sj.leu.2402457.Full Text Link to Item
-
Hanna, Nasser, Rafat Ansari, William Fisher, Jianzhao Shen, Sin Ho Jung, and Alan Sandler. “Etoposide, ifosfamide and cisplatin (VIP) plus concurrent radiation therapy for previously untreated limited small cell lung cancer (SCLC): a Hoosier Oncology Group (HOG) phase II study.” Lung Cancer 35, no. 3 (March 2002): 293–97. https://doi.org/10.1016/s0169-5002(01)00429-9.Full Text Link to Item
-
Sweeney, C. J., F. J. Monaco, S. H. Jung, M. J. Wasielewski, J. Picus, R. H. Ansari, W. M. Dugan, and L. H. Einhorn. “A phase II Hoosier Oncology Group study of vinorelbine and estramustine phosphate in hormone-refractory prostate cancer.” Ann Oncol 13, no. 3 (March 2002): 435–40. https://doi.org/10.1093/annonc/mdf029.Full Text Link to Item
-
Ahn, Chul, Sin-Ho Jung, and Allan Donner. “Application of an adjusted chi2 statistic to site-specific data in observational dental studies.” J Clin Periodontol 29, no. 1 (January 2002): 79–82. https://doi.org/10.1034/j.1600-051x.2002.290112.x.Full Text Link to Item
-
Hanna, N. H., A. B. Sandier, P. J. Loehrer, R. Ansari, S. H. Jung, K. Lane, and L. H. Einhorn. “Maintenance daily oral etoposide versus no further therapy following induction chemotherapy with etoposide plus ifosfamide plus cisplatin in extensive small-cell lung cancer: a Hoosier Oncology Group randomized study.” Ann Oncol 13, no. 1 (January 2002): 95–102. https://doi.org/10.1093/annonc/mdf014.Full Text Link to Item
-
Soergel, T. M., M. O. Koch, R. S. Foster, R. Bihrle, G. Wahle, T. Gardner, and S. H. Jung. “Accuracy of predicting long-term prostate specific antigen outcome based on early prostate specific antigen recurrence results after radical prostatectomy.” J Urol 166, no. 6 (December 2001): 2198–2201.Link to Item
-
Yip-Schneider, M. T., C. J. Sweeney, S. H. Jung, P. L. Crowell, and M. S. Marshall. “Cell cycle effects of nonsteroidal anti-inflammatory drugs and enhanced growth inhibition in combination with gemcitabine in pancreatic carcinoma cells.” J Pharmacol Exp Ther 298, no. 3 (September 2001): 976–85.Link to Item
-
Jung, S. H., M. Carey, and K. M. Kim. “Graphical search for two-stage designs for phase II clinical trials.” Control Clin Trials 22, no. 4 (August 2001): 367–72. https://doi.org/10.1016/s0197-2456(01)00142-8.Full Text Link to Item
-
Ahluwalia, A., P. Yan, J. A. Hurteau, R. M. Bigsby, S. H. Jung, T. H. Huang, and K. P. Nephew. “DNA methylation and ovarian cancer. I. Analysis of CpG island hypermethylation in human ovarian cancer using differential methylation hybridization.” Gynecol Oncol 82, no. 2 (August 2001): 261–68. https://doi.org/10.1006/gyno.2001.6291.Full Text Link to Item
-
Wagner, J. D., D. S. Schauwecker, D. Davidson, S. Wenck, S. H. Jung, and G. Hutchins. “FDG-PET sensitivity for melanoma lymph node metastases is dependent on tumor volume.” J Surg Oncol 77, no. 4 (August 2001): 237–42. https://doi.org/10.1002/jso.1102.Full Text Link to Item
-
Jung, S. H., C. Ahn, and A. Donner. “Evaluation of an adjusted chi-square statistic as applied to observational studies involving clustered binary data.” Stat Med 20, no. 14 (July 30, 2001): 2149–61. https://doi.org/10.1002/sim.857.Full Text Link to Item
-
Jung, S. H., S. H. Kang, and C. Ahn. “Sample size calculations for clustered binary data.” Stat Med 20, no. 13 (July 15, 2001): 1971–82. https://doi.org/10.1002/sim.846.Full Text Link to Item
-
Jung, S. H., and S. H. Kang. “Tests for 2 x K contingency tables with clustered ordered categorical data.” Stat Med 20, no. 5 (March 15, 2001): 785–94. https://doi.org/10.1002/sim.705.Full Text Link to Item
-
Kang, S. H., and S. H. Jung. “Generating correlated binary variables with complete specification of the joint distribution.” Biometrical Journal 43, no. 3 (2001): 263–69. https://doi.org/10.1002/1521-4036(200106)43:3<263::AID-BIMJ263>3.0.CO;2-5.Full Text
-
Ulrich, E. M., A. Caperell-Grant, S. H. Jung, R. A. Hites, and R. M. Bigsby. “Environmentally relevant xenoestrogen tissue concentrations correlated to biological responses in mice.” Environ Health Perspect 108, no. 10 (October 2000): 973–77. https://doi.org/10.1289/ehp.00108973.Full Text Link to Item
-
Koch, M. O., R. S. Foster, B. Bell, S. Beck, L. Cheng, D. Parekh, and S. H. Jung. “Characterization and predictors of prostate specific antigen progression rates after radical retropubic prostatectomy.” J Urol 164, no. 3 Pt 1 (September 2000): 749–53. https://doi.org/10.1097/00005392-200009010-00030.Full Text Link to Item
-
Wagner, J. D., M. S. Gordon, T. Y. Chuang, J. J. Coleman, J. T. Hayes, S. H. Jung, and C. Love. “Predicting sentinel and residual lymph node basin disease after sentinel lymph node biopsy for melanoma.” Cancer 89, no. 2 (July 15, 2000): 453–62. https://doi.org/10.1002/1097-0142(20000715)89:2<453::aid-cncr34>3.0.co;2-v.Full Text Link to Item
-
Emir, B., S. Wieand, S. H. Jung, and Z. Ying. “Comparison of diagnostic markers with repeated measurements: a non-parametric ROC curve approach.” Stat Med 19, no. 4 (February 29, 2000): 511–23. https://doi.org/10.1002/(sici)1097-0258(20000229)19:4<511::aid-sim353>3.0.co;2-3.Full Text Link to Item
-
Jung, S. H., and C. Ahn. “Estimation of response probability in correlated binary data: A new approach.” Drug Information Journal 34, no. 2 (2000): 599–604.
-
Koch, M. O., R. S. Foster, B. Bell, S. Beck, L. Cheng, D. Parekh, and S. H. Jung. “Characterization and predictors of prostate specific antigen progression rates after radical retropubic prostatectomy.” Journal of Urology 164, no. 3 I (January 1, 2000): 749–53. https://doi.org/10.1016/s0022-5347(05)67295-3.Full Text
-
Jung, S. H., and S. Wieand. “Analysis of goodness-of-fit for Cox regression model.” Statistics and Probability Letters 41, no. 2 (February 15, 1999): 379–82. https://doi.org/10.1016/s0167-7152(98)00152-7.Full Text
-
Jung, S. H. “Rank tests for matched survival data.” Lifetime Data Anal 5, no. 1 (1999): 67–79. https://doi.org/10.1023/a:1009635201363.Full Text Link to Item
-
Edmonson, J. H., L. P. Ebbert, A. G. Nascimento, S. H. Jung, H. McGaw, and J. B. Gerstner. “Phase II study of docetaxel in advanced soft tissue sarcomas.” Am J Clin Oncol 19, no. 6 (December 1996): 574–76. https://doi.org/10.1097/00000421-199612000-00008.Full Text Link to Item
-
Schleusener, J. T., H. D. Tazelaar, S. H. Jung, S. S. Cha, P. J. Cera, J. L. Myers, E. T. Creagan, R. M. Goldberg, and R. F. Marschke. “Neuroendocrine differentiation is an independent prognostic factor in chemotherapy-treated nonsmall cell lung carcinoma.” Cancer 77, no. 7 (April 1, 1996): 1284–91. https://doi.org/10.1002/(SICI)1097-0142(19960401)77:7<1284::AID-CNCR9>3.0.CO;2-I.Full Text Link to Item
-
Jung, S. H. “Quasi-likelihood for median regression models.” Journal of the American Statistical Association 91, no. 433 (March 1, 1996): 251–57. https://doi.org/10.1080/01621459.1996.10476683.Full Text
-
Jung, S. H. “Regression analysis for long-term survival rate.” Biometrika 83, no. 1 (January 1, 1996): 227–32. https://doi.org/10.1093/biomet/83.1.227.Full Text
-
Rowland, K. M., C. L. Loprinzi, E. G. Shaw, A. W. Maksymiuk, S. A. Kuross, S. H. Jung, J. W. Kugler, et al. “Randomized double-blind placebo-controlled trial of cisplatin and etoposide plus megestrol acetate/placebo in extensive-stage small-cell lung cancer: a North Central Cancer Treatment Group study.” J Clin Oncol 14, no. 1 (January 1996): 135–41. https://doi.org/10.1200/JCO.1996.14.1.135.Full Text Link to Item
-
Creagan, E. T., R. J. Dalton, D. L. Ahmann, S. H. Jung, R. F. Morton, R. M. Langdon, J. Kugler, and L. J. Rodrigue. “Randomized, surgical adjuvant clinical trial of recombinant interferon alfa-2a in selected patients with malignant melanoma.” J Clin Oncol 13, no. 11 (November 1995): 2776–83. https://doi.org/10.1200/JCO.1995.13.11.2776.Full Text Link to Item
-
Jung, S. H., S. Wieand, and S. S. Cha. “A statistic for comparing two correlated markers which are prognostic for time to an event.” Stat Med 14, no. 20 (October 30, 1995): 2217–25. https://doi.org/10.1002/sim.4780142005.Full Text Link to Item
-
Jett, J. R., R. J. Kirschling, S. H. Jung, and R. S. Marks. “A phase II study of paclitaxel and granulocyte colony-stimulating factor in previously untreated patients with extensive-stage small cell lung cancer: A study of the North Central Cancer Treatment Group.” Seminars in Oncology 22, no. 3 SUPPL. 6 (July 10, 1995): 75–77.
-
Jett, J. R., R. J. Kirschling, S. H. Jung, and R. S. Marks. “A phase II study of paclitaxel and granulocyte colony-stimulating factor in previously untreated patients with extensive-stage small cell lung cancer: a study of the North Central Cancer Treatment Group.” Semin Oncol 22, no. 3 Suppl 6 (June 1995): 75–77.Link to Item
-
Kottke, T. E., M. A. Trapp, M. M. Fores, A. W. Kelly, S. H. Jung, P. J. Novotny, and L. A. Panser. “Cancer screening behaviors and attitudes of women in southeastern Minnesota.” Jama 273, no. 14 (April 12, 1995): 1099–1105.Link to Item
-
Jung, S. H., and J. Q. Su. “Non-parametric estimation for the difference or ratio of median failure times for paired observations.” Stat Med 14, no. 3 (February 15, 1995): 275–81. https://doi.org/10.1002/sim.4780140306.Full Text Link to Item
-
Ying, Z., S. H. Jung, and L. J. Wei. “Survival analysis with median regression models.” Journal of the American Statistical Association 90, no. 429 (January 1, 1995): 178–84. https://doi.org/10.1080/01621459.1995.10476500.Full Text
-
Cunningham, J. M., J. N. Ingle, S. H. Jung, S. S. Cha, L. E. Wold, G. Farr, T. E. Witzig, J. E. Krook, H. S. Wieand, and J. S. Kovach. “p53 gene expression in node-positive breast cancer: relationship to DNA ploidy and prognosis.” J Natl Cancer Inst 86, no. 24 (December 21, 1994): 1871–73. https://doi.org/10.1093/jnci/86.24.1871.Full Text Link to Item
-
Ingle, J. N., S. A. Kuross, J. A. Mailliard, C. L. Loprinzi, S. H. Jung, R. A. Nelimark, J. E. Krook, and H. J. Long. “Evaluation of piroxantrone in women with metastatic breast cancer and failure on nonanthracycline chemotherapy.” Cancer 74, no. 6 (September 15, 1994): 1733–38. https://doi.org/10.1002/1097-0142(19940915)74:6<1733::aid-cncr2820740615>3.0.co;2-d.Full Text Link to Item
-
Ingle, J. N., J. F. Foley, J. A. Mailliard, J. E. Krook, L. C. Hartmann, S. H. Jung, M. H. Veeder, D. H. Gesme, A. K. Hatfield, and R. M. Goldberg. “Randomized trial of cyclophosphamide, methotrexate, and 5-fluorouracil with or without estrogenic recruitment in women with metastatic breast cancer.” Cancer 73, no. 9 (May 1, 1994): 2337–43. https://doi.org/10.1002/1097-0142(19940501)73:9<2337::aid-cncr2820730916>3.0.co;2-q.Full Text Link to Item
-
Gisvold, J. J., J. R. Goellner, C. S. Grant, J. H. Donohue, M. W. Sykes, P. R. Karsell, S. L. Coffey, and S. H. Jung. “Breast biopsy: a comparative study of stereotaxically guided core and excisional techniques.” Ajr Am J Roentgenol 162, no. 4 (April 1994): 815–20. https://doi.org/10.2214/ajr.162.4.8140997.Full Text Link to Item
-
Cheng, Jeffrey, Sin-Ho Jung, and Junheng Gao. “Clinical Factors Affecting Survival in Pediatric Vascular Tumors of the Head and Neck.” J Craniofac Surg 31, no. 3 (n.d.): 628–29. https://doi.org/10.1097/SCS.0000000000006040.Full Text Link to Item
-
-
Conference Papers
-
Sarver, M. M., J. D. Rames, G. M. Beasley, J. Gao, S. Jung, and S. C. Chen. “Improved survival of multiple vs single primary melanomas.” In Journal of Investigative Dermatology, 142:S32–S32, 2022.Link to Item
-
Farrow, N. E., E. K. Holl, J. Jung, J. Gao, S. Jung, R. Al-Rohil, P. Mosca, et al. “An Immune Tolerant Sentinel Node Microenvironment Predicts Recurrence in Melanoma.” In Annals of Surgical Oncology, 27:S32–S32. SPRINGER, 2020.Link to Item
-
Choi, Wonyoung, Jong Gwang Kim, Seung-Hoon Beom, Jun-Eul Hwang, Hyun-Jung Shim, Sang-Hee Cho, Min-Ho Shin, et al. “Immunogenicity and Optimal Timing of 13-Valent Pneumococcal Conjugate Vaccination during Adjuvant Chemotherapy in Gastric and Colorectal Cancer: A Randomized Controlled Trial.” In Cancer Res Treat, 52:246–53, 2020. https://doi.org/10.4143/crt.2019.189.Full Text Link to Item
-
Jacobs, C. D., R. Kahmke, D. J. Rocke, I. Barak, S. H. Jung, G. Suneja, and Y. M. Mowery. “Nomogram to Predict Survival Benefit of Postoperative Radiotherapy for Major Salivary Gland Cancers.” In International Journal of Radiation Oncology*Biology*Physics, 105:S183–S183. Elsevier BV, 2019. https://doi.org/10.1016/j.ijrobp.2019.06.227.Full Text
-
Han, Sangbin, Ji Hye Kwon, Sun Hee Jung, Ji Young Seo, Yong Jun Jo, Jin Sung Jang, Seung Min Yeon, et al. “Perioperative Fresh Red Blood Cell Transfusion May Negatively Affect Recipient Survival After Liver Transplantation.” In Ann Surg, 267:346–51, 2018. https://doi.org/10.1097/SLA.0000000000002062.Full Text Link to Item
-
McCarthy, P. L., S. A. Holstein, S. -. H. Jung, M. Cooper, C. J. Gibson, E. A. Stadtmauer, B. Winograd, and P. Richardson. “LENALIDOMIDE MAINTENANCE VS PLACEBO AFTER STEM CELL TRANSPLANT FOR PATIENTS WITH MULTIPLE MYELOMA: OVERALL SURVIVAL AND PROGRESSION-FREE SURVIVAL AFTER ADJUSTING FOR TREATMENT CROSSOVER IN CALGB.” In Haematologica, 102:108–108. FERRATA STORTI FOUNDATION, 2017.Link to Item
-
Straus, D., B. Pitcher, L. Kostakoglu, J. C. Grecula, E. D. Hsi, H. Schoder, S. -. H. Jung, et al. “RESULTS OF US INTERGROUP TRIAL OF RESPONSE-ADAPTED CHEMOTHERAPY OR CHEMOTHERAPY/RADIATION THERAPY BASED ON PET FOR NON-BULKY STAGE I AND II HODGKIN LYMPHOMA (CALGB/ALLIANCE 50604).” In Haematologica, 101:13–13. FERRATA STORTI FOUNDATION, 2016.Link to Item
-
Lim, S. H., Y. -. L. Choi, S. -. H. Jung, M. -. J. A. Ahn, K. Park, J. I. Zo, Y. M. Shim, and J. -. M. Sun. “A randomized phase II study of leucovorin, 5-fluorouracil with or without oxaliplatin (LV5FU2 vs. FOLFOX) for curatively-resected, node-positive esophageal squamous cell carcinoma.” In Annals of Oncology, 27:vi218–vi218. Elsevier BV, 2016. https://doi.org/10.1093/annonc/mdw371.35.Full Text
-
Um, S. -. W., K. Lee, H. Kim, Y. Choi, J. Kim, Y. Shim, J. Han, S. -. H. Jung, and O. Kwon. “A Prospective Study Of Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration Compared With MediastINOScopy For Mediastinal Nodal Staging Of Non-Small Cell Lung Cancer.” In American Journal of Respiratory and Critical Care Medicine, Vol. 187. AMER THORACIC SOC, 2013.Link to Item
-
Smith, S. M., N. Bartlett, J. L. Johnson, A. Cashen, J. Lister, S. -. H. Jung, H. Schoder, K. Egan, and B. D. Cheson. “GALIXIMAB, AN ANTI-CD80 PRIMATIZED MONOCLONAL ANTIBODY, IN RELAPSED HODGKIN LYMPHOMA (HL): FINAL RESULTS OF CALGB 50602.” In Haematologica, 95:S32–S32. FERRATA STORTI FOUNDATION, 2010.Link to Item
-
Feng, L., F. L. Jayes, S. -. H. Jung, and P. C. Leppert. “Vitamin D receptor (VDR) is over-expressed in the center of uterine fibroids.” In Fertility and Sterility, 94:S75–S75. Elsevier BV, 2010. https://doi.org/10.1016/j.fertnstert.2010.07.291.Full Text
-
Hsi, Eric D., Jonathan Said, Jeffrey L. Johnson, Sinho Jung, Raymond Lai, Dan Jones, Amy Chadburn, Bruce D. Cheson, and Wyndham H. Wilson. “Biologic Prognostic Markers in Diffuse Large B-Cell Lymphoma Patients Treated with Dose Adjusted EPOCH-R: a CALGB 50103 Correlative Science Study.” In Blood, 112:181–181. AMER SOC HEMATOLOGY, 2008.Link to Item
-
Augustine, C., A. N. Potti, S. H. Jung, J. Nevins, and D. S. Tyler. “Targeted therapy for in-transit melanoma: Utility of gene expression signatures to define optimal strategy.” In Annals of Surgical Oncology, 14:67–68. SPRINGER, 2007.Link to Item
-
Lai, R., E. D. Hsi, J. Mackey, S. Jung, J. L. Johnson, J. R. Cook, D. Jones, J. W. Said, B. D. Cheson, and N. L. Bartlett. “High expression of nucleoside transporter hENT1 predicts a worse event-free survival in relapsed/refractory Hodgkin lymphoma patients treated with gemcitabine, vinorelbine, and liposomal doxorubicin - A CALGB 59804 correlative study.” In Journal of Clinical Oncology, 24:442S-442S. AMER SOC CLINICAL ONCOLOGY, 2006.Link to Item
-
Jung, S. H., T. Lee, K. M. Kim, and S. L. George. “Admissible two-stage designs for phase II cancer clinical trials.” In Controlled Clinical Trials, 24:61S-61S, 2003.Link to Item
-
Jung, Sin-Ho, Kouros Owzar, and Stephen George. “Associating Microarray Data with a Survival Endpoint,” 109–20. Kluwer Academic Publishers, n.d. https://doi.org/10.1007/0-387-23077-7_9.Full Text
-
-
- Teaching & Mentoring
-
Recent Courses
Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.